var title_f8_35_8752="Pediatric purpura algorithm";
var content_f8_35_8752=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F78063&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F78063&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pediatric purpura algorithm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 638px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     &nbsp;",
"    </p>",
"    <div class=\"footnotes\">",
"     CBC: complete blood count; PT: prothrombin time; aPTT: activated partial thromboplastin time; DIC: disseminated intravascular coagulation; ITP: idiopathic thrombocytopenic purpura; HSP: Henoch Schoelein purpura; HUS: hemolytic uremic syndrome; TTP: thrombotic thrombocytopenic purpura.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Leslie Raffini, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8752=[""].join("\n");
var outline_f8_35_8752=null;
var title_f8_35_8753="Lynestrenol: International drug information";
var content_f8_35_8753=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Lynestrenol: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4304139\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Exlutena (SE);",
"     </li>",
"     <li>",
"      Exluton (AR, BE, CZ, FI, FR, LU, MX, NL, PT, ZA);",
"     </li>",
"     <li>",
"      Exlutona (CH, DE, NO);",
"     </li>",
"     <li>",
"      Orgametril (AT, BE, CH, CZ, DE, DK, ES, FI, FR, HU, IN, LU, NL, PT, SE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F1979378\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Lynoestrenol",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1979380\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Progestin",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1979383\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of endometriosis; prevention of pregnancy",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1979379\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: One tablet daily",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1979382\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: 0.5 mg, 5 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10408 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-183.166.191.243-B4DFEB0FC9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8753=[""].join("\n");
var outline_f8_35_8753=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4304139\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979378\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979380\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979383\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979379\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821117\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979382\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10408\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10408|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_35_8754="Recoverin and photoreceptors";
var content_f8_35_8754=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F67930&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F67930&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anti-recoverin antibodies",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 247px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Section of bovine retina incubated with the serum of a patient with cancer-associated retinopathy and anti-recoverin antibodies that are targeted against the photoreceptors. The antibodies specifically react with the photoreceptors (seen in brown).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Josep Dalmau, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8754=[""].join("\n");
var outline_f8_35_8754=null;
var title_f8_35_8755="Mother on her side";
var content_f8_35_8755=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55925&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55925&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Mother on her side",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Comparison of positions for pushing and delivery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wolters Kluwer. Copyright &copy;2009.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8755=[""].join("\n");
var outline_f8_35_8755=null;
var title_f8_35_8756="Ultrasound of acardiac twin";
var content_f8_35_8756=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F53045&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F53045&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 505px\">",
"   <div class=\"ttl\">",
"    Ultrasound of acardiac twin",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 485px; height: 345px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Coronal view of an acardiac twin shows poorly developed cranium (arrow). In the expected region of the fetal heart (arrowhead), a cystic area is visible without cardiac activity. Note the edematous subcutaneous tissues.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Deborah Levine, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8756=[""].join("\n");
var outline_f8_35_8756=null;
var title_f8_35_8757="2D TTE parasternal long axis";
var content_f8_35_8757=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77446%7ECARD%2F56587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77446%7ECARD%2F56587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Two-dimensional transthoracic echocardiogram (2D TTE) parasternal long axis view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 299px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This parasternal long axis echocardiogram was obtained in systole; the aortic valve is open and the mitral is closed.",
"    <div class=\"footnotes\">",
"     RV: right ventricle; IVS: interventricular septum; NCC: noncoronary cusp of the aortic valve; PW: posterior left ventricle wall; RCC: right coronary cusp of the aortic valve; aML: anterior mitral valve leaflet; pML: posterior mitral valve leaftlet; dAo: descending aorta.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Two-dimensional transthoracic echocardiogram (2D TTE) right ventricular (RV) inflow view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 402px; height: 291px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The parasternal&nbsp;right ventricular (RV)&nbsp;inflow view&nbsp;from the two-dimensional echocardiogram shows the RV and atrium (RA) and the septal and&nbsp;anterior leaflets of the tricuspid valve (TV). The entrance of the coronary sinus into the RA is separated from the entrance of the inferior vena cava by the eustachian valve (EV).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8757=[""].join("\n");
var outline_f8_35_8757=null;
var title_f8_35_8758="Cutaneous neurofibroma";
var content_f8_35_8758=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F82612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F82612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cutaneous neurofibroma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cutaneous neurofibromas are soft, flesh-colored papules or nodules. This patient had a solitary lesion unassociated with neurofibromatosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8758=[""].join("\n");
var outline_f8_35_8758=null;
var title_f8_35_8759="Clinical syndromes of stunned or hibernating myocardium";
var content_f8_35_8759=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical syndromes of stunned or hibernating myocardium",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/35/8759/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/35/8759/contributors\">",
"     David M Shavelle, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/35/8759/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/35/8759/contributors\">",
"     Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/35/8759/contributors\">",
"     Jeroen J Bax, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/35/8759/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/35/8759/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/35/8759/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 12, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Left ventricular (LV) dysfunction, which may be an important consequence of coronary artery disease, can result from acute myocardial ischemia or myocardial infarction (MI) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In addition, two other clinical syndromes can be associated with LV dysfunction:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Transient postischemic dysfunction, called \"stunned\" myocardium",
"     </li>",
"     <li>",
"      Chronic, but potentially reversible, ischemic dysfunction, called \"hibernating\" myocardium",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with the latter disorder, LV function may improve markedly and mortality may be reduced following successful coronary revascularization. The time course of recovery is variable.",
"   </p>",
"   <p>",
"    The clinical syndromes associated with stunned and hibernating myocardium and the methods used to detect stunned myocardium will be reviewed here. The pathophysiology of these disorders and the diagnosis and treatment of hibernating myocardium are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23335?source=see_link\">",
"     \"Pathophysiology of stunned or hibernating myocardium\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/41/10905?source=see_link\">",
"     \"Evaluation of hibernating myocardium\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24633?source=see_link\">",
"     \"Diagnosis and management of ischemic cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL SYNDROMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stunned myocardium follows an episode of acute coronary ischemia. In comparison, hibernating myocardium occurs in the clinical syndromes of unstable and chronic stable angina, and LV dysfunction, or heart failure (HF). Stunned myocardium and hibernating myocardium may coexist in some patients. Research also suggests that hibernating myocardium may occur from repetitive episodes of stunning [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Stable angina",
"    </span>",
"    &nbsp;&mdash;&nbsp;Support for the role of stunned or hibernating myocardium in stable angina comes from several observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with coronary artery disease and chronic stable angina, prolonged, but reversible LV dysfunction (stunning) occurred after a symptom-limited",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      infusion despite normal myocardial blood flow and myocardial oxygen consumption [",
"      <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/4\">",
"       4",
"      </a>",
"      ]. The degree of stunning was related to the severity of the coronary stenosis and the reduction in peak myocardial blood flow.",
"     </li>",
"     <li>",
"      LV dysfunction at rest in some patients with chronic stable angina improves after revascularization with CABG or PTCA [",
"      <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/5-12\">",
"       5-12",
"      </a>",
"      ]. In one angioplasty study, for example, 59 of 81 (73 percent) of hypokinetic or akinetic segments improved after revascularization [",
"      <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/12\">",
"       12",
"      </a>",
"      ]. With multivariate analysis, the best predictor of improvement in resting LV ejection fraction (LVEF) after CABG was the number of viable, asynergic myocardial segments per patient demonstrated on a resting thallium perfusion scan, that is, the number of segments that were hibernating; there was no correlation with the degree of angina [",
"      <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Recovery may also be related to the degree of ischemia. One study using quantitative thallium-201 imaging after exercise and with redistribution, showed that improvement was more likely in regions with persistent defects with a 25 to 50 percent reduction in thallium uptake compared to regions with persistent defects in which thallium uptake was reduced by &gt;50 percent (59 versus 21 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reinjection of a second smaller dose of thallium immediately following the redistribution images improves the detection of stress defect reversibility [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/14\">",
"     14",
"    </a>",
"    ]. This method can identify viable territories in as many as 50 to 70 percent of regions which were deemed scar by the standard three to four hour redistribution protocols [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. The positive and negative predictive values for improvement in perfusion and wall motion are in the range of 85 percent with this technique, significantly higher than those of redistribution imaging alone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/33/23066?source=see_link\">",
"     \"Assessment of myocardial viability by nuclear imaging in coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An equally accurate method for establishing hibernation is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    echocardiography which examines the inotropic or contractile reserve of dysfunctional but viable myocardium. Viable myocardium shows improved regional contractile function (inotropic reserve), as assessed by simultaneous transthoracic echocardiography, and increased metabolic activity in response to low dose dobutamine [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/18/15656?source=see_link\">",
"     \"Dobutamine stress echocardiography in the evaluation of hibernating myocardium\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/41/10905?source=see_link\">",
"     \"Evaluation of hibernating myocardium\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Unstable angina",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unstable angina encompasses a variety of clinical conditions including the new onset of chest pain, progressive effort angina, rest angina, and post MI angina. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28505?source=see_link\">",
"     \"Classification of unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As described below, severe myocardial ischemia or infarction produces regional wall motion abnormalities on echocardiography or perfusion defects on perfusion imaging. Studies in which coronary occlusion occurred during percutaneous coronary intervention have shown that regional wall motion abnormalities on echocardiography occur within 10 to 30 seconds,",
"    <strong>",
"     before",
"    </strong>",
"    the onset of ECG abnormalities or chest pain (",
"    <a class=\"graphic graphic_figure graphicRef79335 \" href=\"UTD.htm?32/60/33741\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/19-21\">",
"     19-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among patients with unstable angina, the time course of myocardial recovery after the cessation of chest pain is variable, ranging from less than two hours in patients with a short duration of chest pain (&le;10 minutes) to more than 24 hours in patients with prolonged angina [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. This delay in recovery, which occurs in the absence of recurrent chest pain, is thought to reflect myocardial stunning [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/22,24\">",
"     22,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hibernating myocardium also may be present, as patients with unstable angina who have not had a previous MI may have persistent reductions in perfusion and wall motion at rest [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/23\">",
"     23",
"    </a>",
"    ]. Abnormal preoperative regional wall motion function is reversible with CABG in 40 percent of these patients; this improvement in wall motion is associated with an improvement of global LV function [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/25\">",
"     25",
"    </a>",
"    ]. In one series, patients with unstable angina and abnormal preoperative LV function at rest had a 5- and 10-year survival after CABG that was not significantly different from that of patients with normal preoperative LV function [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hibernating myocardium appears to be more common in unstable than stable angina (75 versus 28 percent in one series) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/27\">",
"     27",
"    </a>",
"    ]. The greater frequency of hibernating myocardium may explain why the 10-year survival after CABG in this study was significantly higher in patients with unstable angina and preoperative LV dysfunction than in those with stable angina and preoperative LV dysfunction; in comparison, survival in unstable and stable angina was equivalent among patients who had normal preoperative LV function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Acute myocardial infarction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with an ST elevation MI who are treated with reperfusion therapy have significant stunning with subsequent improvement in myocardial function [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. This was illustrated in the US HEART study which evaluated 249 patients with anterior wall ST elevation MI in whom sequential echocardiograms were obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/28\">",
"     28",
"    </a>",
"    ]. At 90 days, 22 percent of those with abnormal LV function and wall motion abnormalities had complete recovery and an additional 36 percent had partial recovery; most of the improvement occurred by day 14, consistent with the concept of myocardial stunning.",
"   </p>",
"   <p>",
"    Myocardial hibernation in patients with MI can occur both in the area of infarction and in a region of the LV wall at a distance from the infarct [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/26\">",
"     26",
"    </a>",
"    ]. Support for this hypothesis comes from a report of 15 patients with single vessel coronary artery disease who were asymptomatic after an ST elevation MI and had no clinical or exercise-induced evidence of ischemia with thallium imaging; the patients were randomly assigned to either PTCA or conservative medical therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/30\">",
"     30",
"    </a>",
"    ]. After a two month follow-up, patients who underwent PTCA had improvements in coronary blood flow as measured with a Doppler flow wire, the thallium-201",
"    <span class=\"nowrap\">",
"     pathologic/normal",
"    </span>",
"    ratio after exercise, LV wall motion, and LVEF; the patients randomized to medical therapy showed either smaller or no changes in these parameters. These data clearly demonstrate the occurrence of hibernating myocardium in the infarcted area or in an area that was presumed to be infarcted.",
"   </p>",
"   <p>",
"    Hibernating myocardium after MI is associated with a high incidence of subsequent cardiac events. One report evaluated 158 patients with an MI, 57 percent of whom had hibernating myocardium as demonstrated by increased 18-fluorodeoxyglucose (FDG) uptake [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/31\">",
"     31",
"    </a>",
"    ]. After a 23 month follow-up, a cardiac event (cardiac death, nonfatal MI, unstable angina, or late revascularization) occurred much more frequently in patients with evidence of hibernation (33 versus 3 percent). An increase in FDG uptake was the most significant predictor of a subsequent cardiac event, followed by the number of diseased vessels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Severe LV dysfunction or HF",
"    </span>",
"    &nbsp;&mdash;&nbsp;The importance of hibernating myocardium has been evaluated in patients with ischemic cardiomyopathy and those referred for cardiac transplantation. The prevalence of hibernating myocardium was evaluated in a meta-analysis of 24 viability studies involving 3088 patients with coronary artery disease and left ventricular dysfunction who had a mean LVEF of 32 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/32\">",
"     32",
"    </a>",
"    ]. Viability was documented in 42 percent of patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24633?source=see_link\">",
"     \"Diagnosis and management of ischemic cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, it has been estimated that more than 10 percent of patients referred for consideration of cardiac transplantation have an element of hibernating myocardium contributing to severe LV contractile dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. As an example, one study of 112 cardiac transplant recipients found that severe coronary disease was found in all patients with a pretransplant diagnosis of ischemic cardiomyopathy (57 percent of the total population); it was also present in 24 percent of patients with a pretransplant diagnosis of idiopathic dilated cardiomyopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with multivessel coronary artery disease, LV dysfunction, no angina, and the lack of inducible ischemia by stress testing may also derive benefit by surgical revascularization if hibernating myocardium is present [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The decline in LV function that occurs with hibernating myocardium is associated with left ventricular remodeling as manifested by increases in left ventricular end-systolic and end-diastolic volumes and a more spherical shape of the left ventricle [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Revascularization leads to partial reversal of these abnormalities (reverse remodeling) and an increase in LVEF [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/37\">",
"     37",
"    </a>",
"    ]. The degree of improvement is significantly correlated with the number of segments that recover function after revascularization [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The possible benefit of revascularization with CABG or percutaneous coronary intervention in patients with coronary artery disease, left ventricular dysfunction, and areas of hibernating myocardium is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24633?source=see_link\">",
"     \"Diagnosis and management of ischemic cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11393757\">",
"    <span class=\"h1\">",
"     UNCOMMON CAUSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;More recently, isolated case reports suggest that myocardial stunning may also occur following tachycardia-induced cardiomyopathy, use of cardiotoxic chemotherapy, severe hypoxia, and status epilepticus [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/39-42\">",
"     39-42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DETECTION OF STUNNED MYOCARDIUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the setting of one of the clinical syndromes described above, noninvasive evaluation can detect myocardial stunning, although such imaging modalities are not routinely used for this purpose in clinical practice.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myocardial ischemia produces regional wall motion abnormalities (RWMAs) that can be detected echocardiographically within 10 to 30 seconds of acute coronary artery occlusion [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. These changes occur",
"    <strong>",
"     prior",
"    </strong>",
"    to the onset of electrocardiographic changes or the development of symptoms (",
"    <a class=\"graphic graphic_figure graphicRef79335 \" href=\"UTD.htm?32/60/33741\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The time course of recovery after the cessation of chest pain is variable, ranging from less than two hours in patients with a short duration of chest pain (&le;10 minutes) to more than 24 hours in patients with prolonged angina [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/22\">",
"     22",
"    </a>",
"    ]. This delay in recovery, which occurs in the absence of recurrent chest pain, appears to reflect myocardial stunning [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/22,24\">",
"     22,24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/6/11369?source=see_link&amp;anchor=H2#H2\">",
"     \"Role of echocardiography in acute myocardial infarction\", section on 'Diagnosis of MI'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Myocardial contrast echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myocardial contrast echocardiography (MCE) utilizes intravenous infusion of microbubbles, which have a distinct ultrasonic density from blood or tissue and which can traverse the microvasculature, permitting visualization of myocardial perfusion. By providing simultaneous LV function and perfusion information via a single modality, MCE can effectively identify dysfunctional but perfused myocardium [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Dysfunctional segments of the LV following an ischemic insult may represent either infarcted or \"stunned\" tissue. Stunned myocardium has homogeneous myocardial contrast on MCE, representing normal blood flow with an intact microvasculature, implying that reperfusion occurred prior to necrosis. In this setting, systolic function is likely to return over the next several weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8759/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13145?source=see_link\">",
"     \"Contrast echocardiography: Clinical applications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DETECTION OF HIBERNATING MYOCARDIUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The methods use to detect hibernating myocardium are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/41/10905?source=see_link\">",
"     \"Evaluation of hibernating myocardium\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40599841\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      \"Stunned\" myocardium is characterized as transient postischemic dysfunction. Stunned myocardium occurs following an episode of acute ischemia. Routine use of non-invasive tests to detect stunned myocardium is not indicated. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical syndromes'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Detection of stunned myocardium'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      \"Hibernating\" myocardium is characterized as chronic, but potentially reversible, ischemic dysfunction. Hibernating myocardium may be seen in patients with unstable and chronic stable angina, left ventricular dysfunction,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      heart failure. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Detection of hibernating myocardium'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Both stunned and hibernating myocardium may recover function after improvement in the ischemic insult.",
"     </li>",
"     <li>",
"      Left ventricular function often improves following revascularization in patients with hibernating myocardium.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/1\">",
"      Rahimtoola SH. The hibernating myocardium in ischaemia and congestive heart failure. Eur Heart J 1993; 14 Suppl A:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/2\">",
"      Opie LH. The ever expanding spectrum of ischemic left ventricular dysfunction. Cardiovasc Drugs Ther 1994; 8 Suppl 2:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/3\">",
"      Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 2009; 4:1925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/4\">",
"      Barnes E, Hall RJ, Dutka DP, Camici PG. Absolute blood flow and oxygen consumption in stunned myocardium in patients with coronary artery disease. J Am Coll Cardiol 2002; 39:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/5\">",
"      Ragosta M, Beller GA, Watson DD, et al. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87:1630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/6\">",
"      Rees G, Bristow JD, Kremkau EL, et al. Influence of aortocoronary bypass surgery on left ventricular performance. N Engl J Med 1971; 284:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/7\">",
"      Chatterjee K, Swan HJ, Parmley WW, et al. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction. Circulation 1973; 47:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/8\">",
"      Takeishi Y, Tono-oka I, Kubota I, et al. Functional recovery of hibernating myocardium after coronary bypass surgery: does it coincide with improvement in perfusion? Am Heart J 1991; 122:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/9\">",
"      Marwick TH, MacIntyre WJ, Lafont A, et al. Metabolic responses of hibernating and infarcted myocardium to revascularization. A follow-up study of regional perfusion, function, and metabolism. Circulation 1992; 85:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/10\">",
"      Elefteriades JA, Tolis G Jr, Levi E, et al. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993; 22:1411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/11\">",
"      Cohen M, Charney R, Hershman R, et al. Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty. J Am Coll Cardiol 1988; 12:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/12\">",
"      van den Berg EK Jr, Popma JJ, Dehmer GJ, et al. Reversible segmental left ventricular dysfunction after coronary angioplasty. Circulation 1990; 81:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/13\">",
"      Gibson RS, Watson DD, Taylor GJ, et al. Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy. J Am Coll Cardiol 1983; 1:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/14\">",
"      Dilsizian V, Rocco TP, Freedman NM, et al. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/15\">",
"      Ohtani H, Tamaki N, Yonekura Y, et al. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990; 66:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/16\">",
"      Rocco TP, Dilsizian V, McKusick KA, et al. Comparison of thallium redistribution with rest \"reinjection\" imaging for the detection of viable myocardium. Am J Cardiol 1990; 66:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/17\">",
"      Inglese E, Brambilla M, Dondi M, et al. Assessment of myocardial viability after thallium-201 reinjection or rest-redistribution imaging: a multicenter study. The Italian Group of Nuclear Cardiology. J Nucl Med 1995; 36:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/18\">",
"      Sun KT, Czernin J, Krivokapich J, et al. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation 1996; 94:3146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/19\">",
"      Hauser AM, Gangadharan V, Ramos RG, et al. Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: echocardiographic observations during coronary angioplasty. J Am Coll Cardiol 1985; 5:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/20\">",
"      Wohlgelernter D, Cleman M, Highman HA, et al. Regional myocardial dysfunction during coronary angioplasty: evaluation by two-dimensional echocardiography and 12 lead electrocardiography. J Am Coll Cardiol 1986; 7:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/21\">",
"      Beller GA. Myocardial perfusion imaging for detection of silent myocardial ischemia. Am J Cardiol 1988; 61:22F.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/22\">",
"      Jeroudi MO, Cheirif J, Habib G, Bolli R. Prolonged wall motion abnormalities after chest pain at rest in patients with unstable angina: a possible manifestation of myocardial stunning. Am Heart J 1994; 127:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/23\">",
"      Brown KA, Okada RD, Boucher CA, et al. Serial thallium-201 imaging at rest in patients with unstable and stable angina pectoris: relationship of myocardial perfusion at rest to presenting clinical syndrome. Am Heart J 1983; 106:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/24\">",
"      Gerber BL, Wijns W, Vanoverschelde JL, et al. Myocardial perfusion and oxygen consumption in reperfused noninfarcted dysfunctional myocardium after unstable angina: direct evidence for myocardial stunning in humans. J Am Coll Cardiol 1999; 34:1939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/25\">",
"      Rankin JS, Newman GE, Muhlbaier LH, et al. The effects of coronary revascularization on left ventricular function in ischemic heart disease. J Thorac Cardiovasc Surg 1985; 90:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/26\">",
"      Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/27\">",
"      Carlson EB, Cowley MJ, Wolfgang TC, Vetrovec GW. Acute changes in global and regional rest left ventricular function after successful coronary angioplasty: comparative results in stable and unstable angina. J Am Coll Cardiol 1989; 13:1262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/28\">",
"      Solomon SD, Glynn RJ, Greaves S, et al. Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med 2001; 134:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/29\">",
"      Sheehan FH, Doerr R, Schmidt WG, et al. Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an important determinant of survival. J Am Coll Cardiol 1988; 12:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/30\">",
"      Montalescot G, Faraggi M, Drobinski G, et al. Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia. Circulation 1992; 86:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/31\">",
"      Tamaki N, Kawamoto M, Takahashi N, et al. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 1993; 22:1621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/32\">",
"      Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/33\">",
"      Luu M, Stevenson LW, Brunken RC, et al. Delayed recovery of revascularized myocardium after referral for cardiac transplantation. Am Heart J 1990; 119:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/34\">",
"      Louie HW, Laks H, Milgalter E, et al. Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. Circulation 1991; 84:III290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/35\">",
"      Bortman G, Sellanes M, Odell DS, et al. Discrepancy between pre- and post-transplant diagnosis of end-stage dilated cardiomyopathy. Am J Cardiol 1994; 74:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/36\">",
"      Paolini G, Lucignani G, Zuccari M, et al. Identification and revascularization of hibernating myocardium in angina-free patients with left ventricular dysfunction. Eur J Cardiothorac Surg 1994; 8:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/37\">",
"      Carluccio E, Biagioli P, Alunni G, et al. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. J Am Coll Cardiol 2006; 47:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/38\">",
"      Rahimtoola SH, La Canna G, Ferrari R. Hibernating myocardium: another piece of the puzzle falls into place. J Am Coll Cardiol 2006; 47:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/39\">",
"      Ishibashi K, Osamura T, Yamahara Y. Myocardial stunning with partial aneurysmal formation generated during the recovering process of tachycardia-induced cardiomyopathy. J Cardiol 2009; 54:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/40\">",
"      Bhakta S, Flick SM, Cooney MM, et al. Myocardial stunning following combined modality combretastatin-based chemotherapy: two case reports and review of the literature. Clin Cardiol 2009; 32:E80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/41\">",
"      Shimizu M, Kagawa A, Takano T, et al. Neurogenic stunned myocardium associated with status epileptics and postictal catecholamine surge. Intern Med 2008; 47:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/42\">",
"      Parasher PS, Daher IN. Myocardial recovery after hypoxia: stunning recovery. Echocardiography 2008; 25:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/43\">",
"      Rakhit DJ, Becher H, Monaghan M, et al. The clinical applications of myocardial contrast echocardiography. Eur J Echocardiogr 2007; 8:S24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/44\">",
"      Ito H, Tomooka T, Sakai N, et al. Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction. Circulation 1993; 87:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/45\">",
"      Main ML, Magalski A, Chee NK, et al. Full-motion pulse inversion power Doppler contrast echocardiography differentiates stunning from necrosis and predicts recovery of left ventricular function after acute myocardial infarction. J Am Coll Cardiol 2001; 38:1390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8759/abstract/46\">",
"      Swinburn JM, Lahiri A, Senior R. Intravenous myocardial contrast echocardiography predicts recovery of dysynergic myocardium early after acute myocardial infarction. J Am Coll Cardiol 2001; 38:19.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1527 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.111.122.2-E64CDCC3B7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8759=[""].join("\n");
var outline_f8_35_8759=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H40599841\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Stable angina",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Unstable angina",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Severe LV dysfunction or HF",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11393757\">",
"      UNCOMMON CAUSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DETECTION OF STUNNED MYOCARDIUM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Myocardial contrast echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DETECTION OF HIBERNATING MYOCARDIUM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40599841\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1527\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1527|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/60/33741\" title=\"figure 1\">",
"      Time course cardiac ischemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/33/23066?source=related_link\">",
"      Assessment of myocardial viability by nuclear imaging in coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28505?source=related_link\">",
"      Classification of unstable angina and non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13145?source=related_link\">",
"      Contrast echocardiography: Clinical applications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24633?source=related_link\">",
"      Diagnosis and management of ischemic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/18/15656?source=related_link\">",
"      Dobutamine stress echocardiography in the evaluation of hibernating myocardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/41/10905?source=related_link\">",
"      Evaluation of hibernating myocardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23335?source=related_link\">",
"      Pathophysiology of stunned or hibernating myocardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/6/11369?source=related_link\">",
"      Role of echocardiography in acute myocardial infarction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_35_8760="Acute otitis media in children: Diagnosis";
var content_f8_35_8760=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"88\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute otitis media in children: Diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/35/8760/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/35/8760/contributors\">",
"     Ellen R Wald, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/35/8760/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/35/8760/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/35/8760/contributors\">",
"     Ellen M Friedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/35/8760/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/35/8760/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/35/8760/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute otitis media (AOM), also called suppurative otitis media, is one of the most frequent diagnoses for children seeking acute medical care [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/1\">",
"     1",
"    </a>",
"    ]. It accounts for a large proportion of pediatric antibiotic prescriptions and is associated with considerable medical expenditures [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of acute otitis media will be reviewed here. The epidemiology, pathogenesis, treatment, and prevention of AOM are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21514?source=see_link\">",
"     \"Acute otitis media in children: Treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42857?source=see_link\">",
"     \"Acute otitis media in children: Prevention of recurrence\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Middle ear effusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Middle ear effusion (MEE) refers to fluid in the middle ear cavity. MEE occurs in both otitis media with effusion and AOM.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Acute otitis media",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute otitis media (AOM) refers to acute bacterial infection of middle ear fluid. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H428761755#H428761755\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Definition'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Otitis media with effusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otitis media with effusion (OME) refers to middle ear fluid that is not infected. OME is also called serous, secretory, or nonsuppurative otitis media. OME frequently precedes the development of AOM or follows its resolution. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=see_link&amp;anchor=H5#H5\">",
"     \"Otitis media with effusion (serous otitis media) in children\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The distinction between OME and AOM may be difficult, since they are part of a continuous spectrum. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21514?source=see_link&amp;anchor=H2#H2\">",
"     \"Acute otitis media in children: Treatment\", section on 'Clinical course'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H25\">",
"     'Otitis media with effusion'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anatomic features of the right tympanic membrane are depicted in the figure (",
"    <a class=\"graphic graphic_figure graphicRef57110 \" href=\"UTD.htm?25/31/26099\">",
"     figure 1",
"    </a>",
"    ). The normal middle ear is aerated, and the tympanic membrane is slightly convex, translucent, mobile, and intact (",
"    <a class=\"graphic graphic_picture graphicRef52626 \" href=\"UTD.htm?5/14/5345\">",
"     picture 1",
"    </a>",
"    ). In contrast, in acute otitis media (AOM), the middle ear is fluid-filled, and the tympanic membrane is usually bulging, yellow or white in color, opaque, and immobile (",
"    <a class=\"graphic graphic_picture graphicRef63268 \" href=\"UTD.htm?1/54/1891\">",
"     picture 2",
"    </a>",
"    ). In some cases, the tympanic membrane may be erythematous, but erythema of the tympanic membrane is a nonspecific finding; it is only helpful in making a diagnosis of AOM if there is concomitant bulging. Increased pressure in the middle ear may lead to central ischemia, necrosis, and perforation of the tympanic membrane.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     IMPORTANCE OF ACCURATE DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The importance of accurate diagnosis of acute otitis media (AOM) cannot be overstated. Accurate diagnosis ensures appropriate treatment for children with AOM, who require antibiotic therapy, and avoidance of antibiotics in children with otitis media with effusion, in whom antibiotics are unnecessary. Accurate diagnosis also prevents overuse of antibiotics, which leads to the development of resistant organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21514?source=see_link\">",
"     \"Acute otitis media in children: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Establishing the diagnosis of AOM in infants and young children can be difficult. The child may not cooperate with the examination, and the tympanic membrane may be obscured by cerumen. In addition, symptoms of AOM may overlap with those of upper respiratory tract infection, or may be subtle or absent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/7-11\">",
"     7-11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H22#H22\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Symptoms and signs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of AOM is facilitated by systematic assessment of the tympanic membrane using a pneumatic otoscope and stringent diagnostic criteria. Pneumatic otoscopy skills, including accurate interpretation of findings, can be improved through training [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Excellent training modules are available online (eg,",
"    <a class=\"external\" href=\"file://pedsed.pitt.edu/06_browse.asp\">",
"     Children's Hospital of Pittsburgh ePROM: Enhancing Proficiency in Otitis Media",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     OTOSCOPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The key to distinguishing acute otitis media (AOM) from otitis media with effusion (OME) is the performance of otoscopy using appropriate tools and an adequate light source (eg, a halogen bulb with brightness &ge;100 foot-candles) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/14\">",
"     14",
"    </a>",
"    ]. The otoscope bulb should be replaced at least every two years, and the battery replaced when outdated [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A pneumatic otoscope with a round head is preferred because it has the best seal (",
"    <a class=\"graphic graphic_picture graphicRef63633 \" href=\"UTD.htm?38/53/39774\">",
"     picture 3",
"    </a>",
"    ). The magnifying glass can be moved aside if and when cerumen removal is necessary. The nipple on the metal head is the site of attachment for the insufflator bulb, which is used to assess mobility of the tympanic membrane. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Mobility'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Cerumen must be removed from the external canal under direct vision in order to be sure that the view of the tympanic membrane is unobstructed. Once cerumen has been removed, systematic assessment of the entire tympanic membrane is undertaken, as described below. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12823?source=see_link&amp;anchor=H9#H9\">",
"     \"Cerumen\", section on 'Cerumen removal'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of AOM requires middle ear effusion (MEE) and acute signs of middle ear inflammation (bulging of the tympanic membrane is the most specific and reproducible sign of middle ear inflammation) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. The classic examination findings include a tympanic membrane that is white, or pale yellow, bulges into the external auditory canal, and has decreased or absent mobility (",
"    <a class=\"graphic graphic_picture graphicRef63268 \" href=\"UTD.htm?1/54/1891\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. However, this constellation of findings is not always present. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Accurate diagnosis of AOM requires systematic evaluation of the tympanic membrane for position, translucency, mobility, color, and other findings (eg, fluid level, perforation). Systematic assessment of the tympanic membrane is facilitated by the use of the COMPLETES mnemonic [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/20\">",
"     20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Color (eg, gray, white, pale yellow, amber, pink, red, blue)",
"     </li>",
"     <li>",
"      Other conditions (eg, fluid level, bubbles, perforation, otorrhea, bullae, tympanosclerosis (scars), atrophic areas, retraction pockets, cholesteatoma)",
"     </li>",
"     <li>",
"      Mobility",
"     </li>",
"     <li>",
"      Position (eg, neutral, retracted, full, or bulging)",
"     </li>",
"     <li>",
"      Lighting (a halogen light source and fully charged battery should be used)",
"     </li>",
"     <li>",
"      Entire surface (the four quadrants of the tympanic membrane should be examined) (",
"      <a class=\"graphic graphic_figure graphicRef57110 \" href=\"UTD.htm?25/31/26099\">",
"       figure 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Translucency",
"     </li>",
"     <li>",
"      External auditory canal and auricle (eg, deformed, displaced, inflamed, foreign body)",
"     </li>",
"     <li>",
"      Seal (a good seal requires an airtight pneumatic system and a speculum that is large enough to prevent air leak)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although the COMPLETES mnemonic serves as a reminder of the important aspects of the otoscopic examination, it reflects neither the order of the examination nor the importance of the individual components in distinguishing AOM from OME [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Experienced otoscopists at a tertiary care children&rsquo;s hospital developed and validated an algorithm that describes the signs and symptoms that they use when diagnosing acute otitis media [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/15\">",
"     15",
"    </a>",
"    ]. The proposed algorithm provides a simple classification scheme to distinguish AOM (bulging tympanic membrane), OME (opacification of the tympanic membrane or air-fluid level), and no middle ear effusion (absence of bulging, opacification, and air-fluid level). Although the cases of AOM, OME, and no middle ear effusions that were used to develop and validate the algorithm were not microbiologically confirmed, the otoscopists had completed a training program in which their diagnoses were validated against myringotomy findings. Expert otoscopists from other centers concurred in the relative importance of the findings of otoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/19\">",
"     19",
"    </a>",
"    ]. We agree that bulging of the tympanic membrane is the crucial finding that differentiates AOM from OME.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Position",
"    </span>",
"    &nbsp;&mdash;&nbsp;The position of the tympanic membrane is the most critical characteristic in distinguishing AOM from OME [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/10,15,17,19\">",
"     10,15,17,19",
"    </a>",
"    ]. Position may be described as neutral, retracted, full, or bulging.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The normal position of the tympanic membrane is neutral (",
"      <a class=\"graphic graphic_picture graphicRef52626 \" href=\"UTD.htm?5/14/5345\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      When there is negative pressure in the middle ear cavity, as may occur in persistent OME, the tympanic membrane is retracted (",
"      <a class=\"graphic graphic_picture graphicRef52819 \" href=\"UTD.htm?18/49/19217\">",
"       picture 4",
"      </a>",
"      ). When the tympanic membrane is retracted, the manubrium of the malleus appears to be shortened, and the lateral process becomes more prominent and closer to the otoscope [",
"      <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/20,21\">",
"       20,21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      When there is infected fluid in the middle ear, the tympanic membrane may appear to be full; larger amounts of infected fluid make it appear to bulge. Bulging is first apparent in the posterosuperior area, where the tympanic membrane is most compliant (",
"      <a class=\"graphic graphic_figure graphicRef57110 \" href=\"UTD.htm?25/31/26099\">",
"       figure 1",
"      </a>",
"      ). When the tympanic membrane is bulging, the malleus is obscured (",
"      <a class=\"graphic graphic_picture graphicRef63268 \" href=\"UTD.htm?1/54/1891\">",
"       picture 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A bulging tympanic membrane is by far the single most important sign of acute inflammation and is the hallmark of AOM [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/10,15,17,19\">",
"     10,15,17,19",
"    </a>",
"    ]. In a large study correlating examination findings with a diagnosis of AOM, the triad of bulging tympanic membrane, impaired mobility, and redness or cloudiness of the tympanic membrane predicted myringotomy diagnosis of AOM in 83 to 99 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/17\">",
"     17",
"    </a>",
"    ]. In another study correlating examination findings with a diagnosis of AOM, 92 percent of children with AOM had a bulging tympanic membrane compared with none of the children with OME or no effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/15\">",
"     15",
"    </a>",
"    ]. In a systematic review, the adjusted LR for bulging tympanic membrane was 51 (95% CI 36-73) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a large study correlating examination findings with a diagnosis of AOM, retracted tympanic membranes were unlikely to be associated with AOM [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/17\">",
"     17",
"    </a>",
"    ]. Normally positioned tympanic membranes were unlikely to be associated with AOM unless mobility was distinctly impaired&nbsp;.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Translucency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Translucency of the tympanic membrane is another important aspect of the examination. The tympanic membrane normally appears translucent (",
"    <a class=\"graphic graphic_picture graphicRef52626 \" href=\"UTD.htm?5/14/5345\">",
"     picture 1",
"    </a>",
"    ). In contrast, the tympanic membrane appears cloudy or opaque when there is fluid in the middle ear. Opacification of the TM is not helpful in differentiating AOM from OME. In a study correlating examination findings with a diagnosis of AOM by experienced otoscopists, opacity of the tympanic membrane was present in 50 of 50 case of AOM and 33 of 34 cases of OME [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An air-fluid level is present when the tympanic membrane appears translucent above and opaque below the line of demarcation (",
"    <a class=\"graphic graphic_picture graphicRef67379 \" href=\"UTD.htm?20/6/20576\">",
"     picture 5",
"    </a>",
"    ). Air fluid levels are more suggestive of OME than AOM [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/15\">",
"     15",
"    </a>",
"    ]. Air-fluid levels fluctuate with pneumatic otoscopy, a technique that helps distinguish fluid levels from scars, which, being part of the tympanic membrane, move with it. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Mobility'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Mobility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumatic assessment of the mobility of the tympanic membrane is an important means of determining the presence MEE, an important criterion for AOM [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/20,22,23\">",
"     20,22,23",
"    </a>",
"    ]. However, in children with AOM, pneumatic otoscopy may be extremely painful. In addition, pneumatic assessment does not indicate whether the fluid is infected and cannot be used in isolation to make a diagnosis of AOM. Bulging remains the single most important sign of AOM. All bulging tympanic membranes have decreased or absent mobility.",
"   </p>",
"   <p>",
"    Mobility of the tympanic membrane is assessed by creating positive and negative pressures within the external auditory canal by using the insufflator bulb of the otoscope. A good seal between the speculum and the external auditory canal is essential in order to make a judgment regarding mobility. A seal cannot be obtained if the tympanic membrane is perforated or contains a patent tympanostomy tube, or if the speculum is too small.",
"   </p>",
"   <p>",
"    To ensure an airtight seal, the largest speculum that fits comfortably into the cartilaginous portion of the external auditory canal should be used (a 4 mm speculum will work for most children) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/20\">",
"     20",
"    </a>",
"    ]. The outer diameter of the speculum may be increased by putting a small piece of rubber tubing around the tip of the speculum [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/21,24\">",
"     21,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A leak in the pneumatic system is another reason for a poor seal. The pneumatic system should be checked for leaks periodically by occluding the tip of the speculum with a finger and squeezing the rubber bulb to see if resistance is felt [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mobility of the tympanic membrane is best visualized in the posterosuperior quadrant or pars flaccida, where the tympanic membrane is most compliant (",
"    <a class=\"graphic graphic_figure graphicRef57110 \" href=\"UTD.htm?25/31/26099\">",
"     figure 1",
"    </a>",
"    ). Positive pressure is created when the insufflator bulb is compressed, and negative pressure when it is released. The tympanic membrane moves away from the observer with positive pressure and toward the observer with negative pressure (",
"    <a class=\"graphic graphic_movie graphicRef55117 \" href=\"UTD.htm?34/4/34895\">",
"     movie 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    When there is high negative pressure in the middle ear cavity, the tympanic membrane may be maximally retracted and unable to move away from the observer with positive pressure (",
"    <a class=\"graphic graphic_movie graphicRef67928 \" href=\"UTD.htm?21/56/22415\">",
"     movie 2",
"    </a>",
"    ). Mobility of a retracted tympanic membrane can be assessed by creating negative pressure in the external auditory canal. The otoscope should be removed from the external canal and the bulb compressed. After the bulb is compressed, the otoscope is reinserted into the external canal. When the seal is secured, the bulb is released, creating negative pressure, which allows the retracted tympanic membrane to move toward the observer into a neutral position.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mobility is described as normal (",
"    <a class=\"graphic graphic_movie graphicRef55117 \" href=\"UTD.htm?34/4/34895\">",
"     movie 1",
"    </a>",
"    ), increased, absent (",
"    <a class=\"graphic graphic_movie graphicRef67928 \" href=\"UTD.htm?21/56/22415\">",
"     movie 2",
"    </a>",
"    ), or decreased.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased mobility of an area of the tympanic membrane may be caused by atrophy (an atrophied tympanic membrane is referred to as \"monomeric\"). The site of a previous perforation or tympanostomy tube also may have increased mobility.",
"     </li>",
"     <li>",
"      Absent or decreased mobility of the tympanic membrane may be caused by MEE (infected or uninfected) or scarring of the tympanic membrane (tympanosclerosis or myringosclerosis) (",
"      <a class=\"graphic graphic_picture graphicRef78073 \" href=\"UTD.htm?16/62/17379\">",
"       picture 6",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The finding of decreased or absent mobility of the tympanic membrane can confirm a diagnosis of MEE. When using this criterion to establish MEE, it is essential that the adequacy of the seal be assured; if it is not, the diagnosis of middle ear effusion may be faulty. Decreased or absent mobility should not be used as the sole criterion for AOM since it provides no information regarding whether the fluid is infected or uninfected. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In a study correlating examination findings with a diagnosis of AOM by experienced otoscopists, decreased mobility of the tympanic membrane was present in 50 of 50 cases of AOM and 23 of 34 cases of OME [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Color",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of the color of the tympanic membrane is another important aspect of the otoscopic examination.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Under normal conditions, the color of the tympanic membrane is pearly gray or pink (",
"      <a class=\"graphic graphic_picture graphicRef52626 \" href=\"UTD.htm?5/14/5345\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      When there is uninfected fluid in the middle ear (ie, OME), the color is usually amber, gray, or blue.",
"     </li>",
"     <li>",
"      A white or pale yellow tympanic membrane usually indicates pus in the middle ear cavity, which is a sign of AOM (",
"      <a class=\"graphic graphic_picture graphicRef63268 \" href=\"UTD.htm?1/54/1891\">",
"       picture 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Chalky white marks usually reflect scarring, also known as myringosclerosis or tympanosclerosis (",
"      <a class=\"graphic graphic_picture graphicRef78073 \" href=\"UTD.htm?16/62/17379\">",
"       picture 6",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A red or hemorrhagic-appearing tympanic membrane may indicate acute inflammation, but a hyperemic tympanic membrane also may be caused by vasodilatation related to manipulation of the canal (as occurs during removal of cerumen), crying, or high fever.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The finding of an erythematous tympanic membrane is less important in the diagnosis of AOM than assessment of the position and mobility [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/10,15,17\">",
"     10,15,17",
"    </a>",
"    ]. In a large study correlating otoscopic findings and AOM, a distinctly red tympanic membrane (defined as hemorrhagic, strongly, or moderately red) in the absence of bulging or impaired mobility predicted a diagnosis of AOM in only 15 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/17\">",
"     17",
"    </a>",
"    ]. In a systematic review, the adjusted LR for a distinctly red TM was 8.4 (95% CI 6.7-11) and for a slightly red tympanic membrane was 1.4 (95% CI 1.1-1.8) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Other findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to position, translucency, mobility, and color, the tympanic membrane should be assessed for the following other findings [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/20\">",
"     20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bubbles or fluid levels (",
"      <a class=\"graphic graphic_picture graphicRef67379 \" href=\"UTD.htm?20/6/20576\">",
"       picture 5",
"      </a>",
"      ), which indicate MEE. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Translucency'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute perforation with purulent otorrhea, which satisfies the criteria for diagnosis of AOM provided that otitis externa is excluded. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link\">",
"       \"External otitis: Pathogenesis, clinical features, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bullae, which are caused by inflammation of the tympanic membrane that occurs in association with AOM (",
"      <a class=\"graphic graphic_picture graphicRef86980 \" href=\"UTD.htm?12/26/12706\">",
"       picture 7",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H25#H25\">",
"       \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Bullous myringitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tympanosclerosis, or scarring of the tympanic membrane (",
"      <a class=\"graphic graphic_picture graphicRef78073 \" href=\"UTD.htm?16/62/17379\">",
"       picture 6",
"      </a>",
"      ), which may be the result of chronic middle ear inflammation, perforation, myringotomy with or without tympanostomy tube placement, or trauma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=see_link&amp;anchor=H8#H8\">",
"       \"Otitis media with effusion (serous otitis media) in children\", section on 'Complications'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Atrophic (monomeric) areas, which may be the sequelae of otitis media or its treatment; atrophic areas may have increased mobility. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Mobility'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Retraction pockets (",
"      <a class=\"graphic graphic_picture graphicRef82650 \" href=\"UTD.htm?42/12/43200\">",
"       picture 8",
"      </a>",
"      ), which may be sequelae of otitis media. Retraction pockets can predispose to the development of cholesteatoma (a benign growth of desquamated, stratified, squamous epithelium). A cholesteatoma may appear as a cyst within the tympanic membrane, greasy white debris, or as a mass (",
"      <a class=\"graphic graphic_picture graphicRef76079 \" href=\"UTD.htm?6/8/6272\">",
"       picture 9",
"      </a>",
"      ). If not treated, the cholesteatoma may gradually enlarge, with eventual erosion of the ossicular chain, mastoid bowl, and external auditory canal. Patients with cholesteatoma or suspected cholesteatoma should be referred to an otolaryngologist. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=see_link\">",
"       \"Cholesteatoma in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     TYMPANOMETRY AND ACOUSTIC REFLECTOMETRY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tympanometry and acoustic reflectometry are techniques to predict the presence or absence of middle ear effusion. Neither technique provides information regarding whether the fluid is infected or uninfected [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. If tympanometry",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    acoustic reflectometry are normal, acute otitis media is unlikely.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Clinical diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical diagnosis of acute otitis media (AOM) requires bulging of the tympanic membrane or other signs of acute inflammation and middle ear effusion (MEE) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A diagnosis of AOM also can be established if there is acute purulent otorrhea and otitis externa has been excluded [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link&amp;anchor=H191116177#H191116177\">",
"     \"External otitis: Pathogenesis, clinical features, and diagnosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17540419\">",
"    <span class=\"h3\">",
"     Bulging of the tympanic membrane and other signs of acute inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Signs of acute inflammation are necessary to differentiate AOM from otitis media with effusion (OME). The best and most reproducible sign of acute inflammation is distinct fullness or bulging of the tympanic membrane (",
"    <a class=\"graphic graphic_picture graphicRef63268 \" href=\"UTD.htm?1/54/1891\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/10,15,17,19\">",
"     10,15,17,19",
"    </a>",
"    ]. Experienced otoscopists rarely make the diagnosis of AOM in the absence of bulging of the tympanic membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/15,19\">",
"     15,19",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Position'",
"    </a>",
"    above.)",
"    <br/>",
"    <br/>",
"    Marked redness of the tympanic membrane is another sign of acute inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/22\">",
"     22",
"    </a>",
"    ]. However, marked redness of the tympanic membrane without bulging is unusual in AOM [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/15\">",
"     15",
"    </a>",
"    ]. A distinctly red tympanic membrane in the absence of bulging or impaired mobility has a predictive value of only 15 percent for AOM [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/17\">",
"     17",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    Non-otoscopic symptoms such as ear tugging or otalgia must be accompanied by abnormal otoscopic findings to make a diagnosis of AOM. As an example, a child who complains of ear pain may be diagnosed with AOM when he or she also has a bulging tympanic membrane.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17540411\">",
"    <span class=\"h3\">",
"     MEE",
"    </span>",
"    &nbsp;&mdash;&nbsp;MEE can be confirmed by one or both of the following findings on otoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bubbles or an air-fluid level (",
"      <a class=\"graphic graphic_picture graphicRef67379 \" href=\"UTD.htm?20/6/20576\">",
"       picture 5",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Two or more of the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Abnormal color (white, yellow, amber, or blue)",
"     </li>",
"     <li>",
"      Opacity (involving part or all of the tympanic membrane) not due to scarring",
"     </li>",
"     <li>",
"      Impairment of mobility (",
"      <a class=\"graphic graphic_movie graphicRef67928 \" href=\"UTD.htm?21/56/22415\">",
"       movie 2",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    MEE also can be confirmed by",
"    <span class=\"nowrap\">",
"     myringotomy/tympanocentesis,",
"    </span>",
"    but this procedure is rarely performed in the primary care setting [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/5,10\">",
"     5,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MEE is necessary but not sufficient for a diagnosis of AOM; there also must be bulging of the tympanic membrane or other signs of acute inflammation. If a child has MEE but no evidence of acute inflammation, he or she has OME.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Etiologic diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tympanocentesis (aspiration of the middle ear fluid) for culture is required for etiologic diagnosis. Etiologic diagnosis is not necessary in most cases of AOM since the antimicrobial agent can be chosen empirically. However, tympanocentesis is warranted if the patient with AOM appears toxic, has immune deficits, or has failed previous courses of antibiotic therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21514?source=see_link\">",
"     \"Acute otitis media in children: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main consideration in the differential diagnosis of acute otitis media (AOM) is otitis media with effusion (OME).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Otitis media with effusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Middle ear effusion (MEE), with decreased mobility and opacification or cloudiness of the tympanic membrane, occurs in both AOM and OME. However, careful evaluation of the position, color, and other findings of the tympanic membrane can help to distinguish AOM from OME [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8760/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Otoscopy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In AOM, the tympanic membrane is usually bulging (",
"      <a class=\"graphic graphic_picture graphicRef63268 \" href=\"UTD.htm?1/54/1891\">",
"       picture 2",
"      </a>",
"      ); in OME, it is usually retracted (",
"      <a class=\"graphic graphic_picture graphicRef78073 \" href=\"UTD.htm?16/62/17379\">",
"       picture 6",
"      </a>",
"      ) or in the neutral position.",
"     </li>",
"     <li>",
"      In AOM, the tympanic membrane is typically white or pale yellow; in OME, it is typically amber or blue.",
"     </li>",
"     <li>",
"      In AOM, pus may be visualized behind the tympanic membrane (",
"      <a class=\"graphic graphic_picture graphicRef63268 \" href=\"UTD.htm?1/54/1891\">",
"       picture 2",
"      </a>",
"      ); the tympanic membrane may be perforated with acute purulent otorrhea, or bullae may be present. In OME, a fluid level (",
"      <a class=\"graphic graphic_picture graphicRef67379 \" href=\"UTD.htm?20/6/20576\">",
"       picture 5",
"      </a>",
"      ) or bubbles may be seen.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Other conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other conditions share some of the otoscopic and non-otoscopic features of AOM, but the history and physical examination should readily distinguish these conditions from AOM. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link\">",
"     \"External otitis: Pathogenesis, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Redness of tympanic membrane &ndash; Redness of the tympanic membrane may be caused by crying, high fever, upper respiratory infection with congestion and inflammation of the mucosa lining the entire respiratory tract, trauma,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      cerumen removal. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Color'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Decreased or absent mobility of tympanic membrane &ndash; In addition to AOM and OME, decreased or absent mobility of the tympanic membrane may be caused by tympanosclerosis (",
"      <a class=\"graphic graphic_picture graphicRef52819 \" href=\"UTD.htm?18/49/19217\">",
"       picture 4",
"      </a>",
"      ) or a high negative pressure within the middle ear cavity. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Mobility'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ear pain &ndash; Ear pain may be caused by otitis externa, ear trauma, throat infections, foreign body, or temporomandibular joint syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/47/13050?source=see_link\">",
"       \"Evaluation of earache in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?43/38/44642?source=see_link\">",
"       \"Patient information: Ear infections (otitis media) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?15/16/15619?source=see_link\">",
"       \"Patient information: Ear infections (otitis media) in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute otitis media (AOM) is defined by acute bacterial infection of middle ear fluid; it must be distinguished from otitis media with effusion (OME), which is defined by fluid in the middle ear cavity that is not infected. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Terminology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Accurate diagnosis of AOM is facilitated by competent skills in pneumatic otoscopy and adherence to stringent diagnostic criteria. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Importance of accurate diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The key to distinguishing AOM from OME is the performance of otoscopy using appropriate tools and an adequate light source; otoscope bulbs should be replaced at least every two years. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Otoscopy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Systematic assessment of the tympanic membrane includes evaluation of position, translucency, mobility, color, and other findings (eg, air-fluid levels). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical diagnosis of AOM requires a bulging tympanic membrane or other signs of acute inflammation and evidence of middle ear effusion (MEE). A diagnosis of AOM also can be established if the tympanic membrane has perforated, acute purulent otorrhea is present, and otitis externa has been excluded. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Clinical diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MEE, which may indicate either OME or AOM, can be confirmed by the observation of bubbles or an air-fluid level (",
"      <a class=\"graphic graphic_picture graphicRef67379 \" href=\"UTD.htm?20/6/20576\">",
"       picture 5",
"      </a>",
"      ), or at least two of the following (see",
"      <a class=\"local\" href=\"#H17540411\">",
"       'MEE'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Abnormal color (white, yellow, amber, or blue)",
"     </li>",
"     <li>",
"      Opacity not due to scarring (involving part or all of the tympanic membrane)",
"     </li>",
"     <li>",
"      Impaired mobility (",
"      <a class=\"graphic graphic_movie graphicRef67928 \" href=\"UTD.htm?21/56/22415\">",
"       movie 2",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/1\">",
"      Cherry DK, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2005 summary. Adv Data 2007; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/2\">",
"      Bondy J, Berman S, Glazner J, Lezotte D. Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric medicaid cohort. Pediatrics 2000; 105:E72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/3\">",
"      McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002; 287:3096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/4\">",
"      Wald ER. To treat or not to treat. Pediatrics 2005; 115:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/5\">",
"      Pichichero ME. Acute otitis media: Part I. Improving diagnostic accuracy. Am Fam Physician 2000; 61:2051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/6\">",
"      Dowell SF, Marcy SM, Phillips WR, et al. Otitis media--principles of judicious use of antimicrobial agents. Pediatrics 1998; 101:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/7\">",
"      Heikkinen T, Ruuskanen O. Signs and symptoms predicting acute otitis media. Arch Pediatr Adolesc Med 1995; 149:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/8\">",
"      Niemela M, Uhari M, Jounio-Ervasti K, et al. Lack of specific symptomatology in children with acute otitis media. Pediatr Infect Dis J 1994; 13:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/9\">",
"      McCormick DP, Lim-Melia E, Saeed K, et al. Otitis media: can clinical findings predict bacterial or viral etiology? Pediatr Infect Dis J 2000; 19:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/10\">",
"      Rothman R, Owens T, Simel DL. Does this child have acute otitis media? JAMA 2003; 290:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/11\">",
"      Laine MK, T&auml;htinen PA, Ruuskanen O, et al. Symptoms or symptom-based scores cannot predict acute otitis media at otitis-prone age. Pediatrics 2010; 125:e1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/12\">",
"      Silva AB, Hotaling AJ. A protocol for otolaryngology-head and neck resident training in pneumatic otoscopy. Int J Pediatr Otorhinolaryngol 1997; 40:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/13\">",
"      Eavey RD, Santos JI, Arriaga MA, et al. An education model for otitis media care field-tested in Latin America. Otolaryngol Head Neck Surg 1993; 109:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/14\">",
"      Barriga F, Schwartz RH, Hayden GF. Adequate illumination for otoscopy. Variations due to power source, bulb, and head and speculum design. Am J Dis Child 1986; 140:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/15\">",
"      Shaikh N, Hoberman A, Rockette HE, Kurs-Lasky M. Development of an algorithm for the diagnosis of otitis media. Acad Pediatr 2012; 12:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/16\">",
"      Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics 2013; 131:e964.",
"     </a>",
"    </li>",
"    <li>",
"     Karma PH, Sipila MM, Kayaja MJ, Penttila MA. Pneumatic otoscopy and otitis media: The value of different tympanic membrane findings and their combinations. In: Recent advances in otitis media: proceedings of the Fifth International Symposium, Lim DJ, Bluestone CD, Klein JO, et al (Eds), Decker, Burlington, Ontario 1993. p.41.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/18\">",
"      Karma PH, Penttil&auml; MA, Sipil&auml; MM, Kataja MJ. Otoscopic diagnosis of middle ear effusion in acute and non-acute otitis media. I. The value of different otoscopic findings. Int J Pediatr Otorhinolaryngol 1989; 17:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/19\">",
"      Shaikh N, Hoberman A, Kaleida PH, et al. Otoscopic signs of otitis media. Pediatr Infect Dis J 2011; 30:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/20\">",
"      Kaleida PH. The COMPLETES exam for otitis. Contemp Pediatr 1997; 14:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/21\">",
"      Pelton SI. Otoscopy for the diagnosis of otitis media. Pediatr Infect Dis J 1998; 17:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/22\">",
"      Hoberman A, Paradise JL. Acute otitis media: diagnosis and management in the year 2000. Pediatr Ann 2000; 29:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/23\">",
"      Jones WS, Kaleida PH. How helpful is pneumatic otoscopy in improving diagnostic accuracy? Pediatrics 2003; 112:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/24\">",
"      Cavanaugh RM Jr. Obtaining a seal with otic specula: must we rely on an air of uncertainty? Pediatrics 1991; 87:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/25\">",
"      Helenius KK, Laine MK, T&auml;htinen PA, et al. Tympanometry in discrimination of otoscopic diagnoses in young ambulatory children. Pediatr Infect Dis J 2012; 31:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8760/abstract/26\">",
"      Laine MK, T&auml;htinen PA, Helenius KK, et al. Acoustic reflectometry in discrimination of otoscopic diagnoses in young ambulatory children. Pediatr Infect Dis J 2012; 31:1007.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6009 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-F35B292492-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8760=[""].join("\n");
var outline_f8_35_8760=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Middle ear effusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Acute otitis media",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Otitis media with effusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      IMPORTANCE OF ACCURATE DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      OTOSCOPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Translucency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Mobility",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Procedure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Color",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Other findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      TYMPANOMETRY AND ACOUSTIC REFLECTOMETRY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Clinical diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17540419\">",
"      - Bulging of the tympanic membrane and other signs of acute inflammation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17540411\">",
"      - MEE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Etiologic diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Otitis media with effusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Other conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6009\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6009|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/31/26099\" title=\"figure 1\">",
"      Tympanic membrane anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6009|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/14/5345\" title=\"picture 1\">",
"      Normal tympanic membrane",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/54/1891\" title=\"picture 2\">",
"      Acute otitis media",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/53/39774\" title=\"picture 3\">",
"      Pneumatic otoscope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/49/19217\" title=\"picture 4\">",
"      Retracted tympanic membrane",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/6/20576\" title=\"picture 5\">",
"      TM air fluid level",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/62/17379\" title=\"picture 6\">",
"      Scarred tympanic membrane",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/26/12706\" title=\"picture 7\">",
"      Bullous myringitis 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/12/43200\" title=\"picture 8\">",
"      TM retraction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/8/6272\" title=\"picture 9\">",
"      Cholesteatoma pars flaccida",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6009|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?34/4/34895\" title=\"movie 1\">",
"      Normal TM mobility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?21/56/22415\" title=\"movie 2\">",
"      Impaired TM mobility",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=related_link\">",
"      Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42857?source=related_link\">",
"      Acute otitis media in children: Prevention of recurrence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21514?source=related_link\">",
"      Acute otitis media in children: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12823?source=related_link\">",
"      Cerumen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=related_link\">",
"      Cholesteatoma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/47/13050?source=related_link\">",
"      Evaluation of earache in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=related_link\">",
"      External otitis: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=related_link\">",
"      Otitis media with effusion (serous otitis media) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?43/38/44642?source=related_link\">",
"      Patient information: Ear infections (otitis media) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/16/15619?source=related_link\">",
"      Patient information: Ear infections (otitis media) in children (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_35_8761="Gonadotropin releasing hormone agonists for long-term treatment of endometriosis";
var content_f8_35_8761=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Gonadotropin releasing hormone agonists for long-term treatment of endometriosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/35/8761/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/35/8761/contributors\">",
"     Mark D Hornstein, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/35/8761/contributors\">",
"     William E Gibbons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/35/8761/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/35/8761/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/35/8761/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/35/8761/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/35/8761/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic pain due to endometriosis can be treated with medical therapy, surgical intervention, or a combination of both. In most cases, women with chronic pelvic pain (CPP) thought to be due to endometriosis are initially treated empirically with nonsteroidal anti-inflammatory drugs (NSAIDS) and combined estrogen-progestin contraceptives. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28969?source=see_link\">",
"     \"Treatment of chronic pelvic pain in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If these medications do not resolve the pain, laparoscopy is usually performed to determine a definitive diagnosis. If the diagnosis of endometriosis is confirmed at laparoscopy, conservative surgery involving excision, fulguration, or laser vaporization of endometriotic implants and adhesiolysis is often attempted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link&amp;anchor=H15#H15\">",
"     \"Overview of the treatment of endometriosis\", section on 'Conservative surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pain can continue after conservative surgery. Recurrence of endometriosis is estimated as 21.5 percent at two years and 40 to 50 percent at five years after surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/1\">",
"     1",
"    </a>",
"    ]. For women with persistent pain or selected patients who have not responded to empiric treatment with NSAIDs or oral contraceptives [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/2\">",
"     2",
"    </a>",
"    ], administration of a gonadotropin releasing hormone (GnRH) agonist is usually effective.",
"   </p>",
"   <p>",
"    Side effects of GnRH agonists, such as vasomotor symptoms and accelerated bone loss, limit treatment duration to six months. However, treatment can be extended beyond six months if add-back therapy is combined with the GnRH agonist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BASIS FOR HORMONAL TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compared to eutopic endometrium, endometriotic implants are characterized by overproduction of prostaglandins and local production of estrogens and cytokines, which synergize the activities of each other, promote implantation of ectopic endometrium, and cause the pain associated with endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/3\">",
"     3",
"    </a>",
"    ]. In addition, aromatase overactivity results in increased COX2 expression favoring prostaglandin E production, which, in turn, upregulates estrogen synthesis pathways. Interventions that reduce ovarian estrogen production reduce this synergistic process, thereby reducing or eliminating endometriosis-related pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most effective methods for suppressing estrogen production in women of reproductive age are bilateral salpingo-oophorectomy and treatment with a GnRH agonist.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Salpingo-oophorectomy &mdash; Bilateral oophorectomy results in a rapid, deep reduction in estrogen to menopausal levels. Cohort studies indicate that hysterectomy with bilateral salpingo-oophorectomy is highly effective for treatment of pelvic pain caused by endometriosis [",
"      <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/4-6\">",
"       4-6",
"      </a>",
"      ]. However, this procedure induces severe menopausal symptoms and results in sterility. Thus, it is not a practical treatment option for most young women.",
"     </li>",
"     <li>",
"      GnRH agonists &mdash; GnRH agonists are the most widely used hormonal method for suppressing ovarian estrogen production, which is reduced to values found in oophorectomized women. They are highly effective for treatment of pelvic pain caused by endometriosis, and have the advantage that their hypoestrogenic effects are largely reversible upon discontinuation of treatment. Menses typically return 60 to 90 days after cessation of intramuscular therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the United States, three GnRH agonists are approved by the Food and Drug Administration (FDA) for treatment of pelvic pain caused by endometriosis:",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/61/26580?source=see_link\">",
"     nafarelin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/22/9574?source=see_link\">",
"     goserelin",
"    </a>",
"    . They are approved for six months of continuous use for this indication, but may be repeated or continued for an additional six months. The six-month limitation is due to concern about the significant bone loss that occurs with GnRH agonist therapy. Additional GnRH agonists (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/11/9398?source=see_link\">",
"     triptorelin",
"    </a>",
"    ) are available for treatment of prostate cancer; some of these drugs are approved for therapy of endometriosis in other countries (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/10/17573?source=see_link\">",
"     buserelin",
"    </a>",
"    in Canada). Recommended doses for GnRH-agonists are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef56031 \" href=\"UTD.htm?5/10/5291\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PHARMACOLOGY OF GnRH AGONISTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;GnRH agonists are derived from native GnRH by substituting a D-amino acid for the native L-amino acid at position 6 of the native decapeptide (",
"    <a class=\"graphic graphic_table graphicRef73733 \" href=\"UTD.htm?36/26/37292\">",
"     table 2",
"    </a>",
"    ). This substitution makes the agonist resistant to degradation by endopeptidases, thereby increasing the half-life and resulting in prolonged receptor occupancy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During the first 10 days of treatment with these agents, binding to the GnRH receptor stimulates the pituitary to produce luteinizing hormone (LH) and follicle stimulating hormone (FSH). Paradoxically, chronic treatment leads to a decrease in pituitary secretion of LH and FSH due to down-regulation of the GnRH receptor and pituitary desensitization. The fall in pituitary LH and FSH secretion suppresses ovarian follicular growth and ovulation, resulting in low levels of circulating estradiol and progesterone. Women chronically treated with clinically effective doses of parenteral GnRH agonists have circulating estradiol concentrations in the range of menopausal women, approximately 15",
"    <span class=\"nowrap\">",
"     pg/mL.",
"    </span>",
"   </p>",
"   <p>",
"    In addition, GnRH agonists may have direct effects on the endometrium. GnRH receptors are present in endometrial cells and a study in cultured endometrioma cell lines showed increasing concentrations of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    [1000",
"    <span class=\"nowrap\">",
"     ng/mL]",
"    </span>",
"    resulted in inhibition of cell growth [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/8\">",
"     8",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H276284642\">",
"    <span class=\"h2\">",
"     Side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main side effects of GnRH agonists result from the hypoestrogenic state; three-quarters of women treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    become hypoestrogenic within the first four weeks of therapy; 98 percent are hypoestrogenic by eight weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/9\">",
"     9",
"    </a>",
"    ]. Signs and symptoms include amenorrhea, vasomotor symptoms, sleep disturbance due to hot flashes, urogenital atrophy, and accelerated bone loss. Over 80 percent of women treated with leuprolide report vasomotor symptoms, approximately 30 percent report vaginal symptoms (eg, vaginitis) and 30 percent report headaches [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/10\">",
"     10",
"    </a>",
"    ]. The potential for bone loss is a major concern, as accelerated bone loss during treatment of women in their 20s and 30s may increase the risk of osteoporotic fractures when these women reach their 60s and 70s.",
"   </p>",
"   <p>",
"    In 2010, the US Food and Drug Administration issued a warning that men receiving GnRH agonists for prostate cancer were at a small increased risk for diabetes, heart attack, stroke, and sudden death [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/11\">",
"     11",
"    </a>",
"    ]. There is no evidence that these drugs have similar risks in women being treated for endometriosis. Women being treated for endometriosis are much younger than men being treated for prostate cancer, and the doses of GnRH agonists used to treat endometriosis are lower than those used to treat prostate cancer. Given the low baseline risk of cardiovascular disease in young women, a small increase in risk from use of GnRH agonists would be difficult to detect, even in large epidemiological studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EFFICACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment with a GnRH agonist reduces endometriosis disease activity as objectively measured by pretreatment and posttreatment surgical staging, and subjectively decreases pelvic pain [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/10,12-17\">",
"     10,12-17",
"    </a>",
"    ]. As an example, in one trial, 52 women with surgically proven endometriosis and pelvic pain were randomly assigned to receive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    acetate (3.75 mg intramuscularly) or a placebo injection every four weeks for six months [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/10\">",
"     10",
"    </a>",
"    ]. Eighty-two percent of women treated with leuprolide acetate completed the trial and 85 percent of these women reported a significant decrease in dysmenorrhea, pelvic pain, and dyspareunia. By comparison, 95 percent of women treated with placebo left the clinical trial because of continuing pelvic pain.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=see_link\">",
"     Danazol",
"    </a>",
"    is also an effective therapy of endometriosis. A systematic review of 15 randomized trials comparing GnRH agonists to danazol concluded they were similarly effective for reduction in pain and endometriotic implants [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/15\">",
"     15",
"    </a>",
"    ]. However, the side effect profile of danazol is worse than that of GnRH agonists. This was illustrated in a trial of 213 women with surgically proven endometriosis who were randomly assigned to receive danazol (800 mg orally) or one of two doses of nasal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/61/26580?source=see_link\">",
"     nafarelin",
"    </a>",
"    (400 mcg or 800 mcg) daily for six months [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/12\">",
"     12",
"    </a>",
"    ]. The three regimens had similar efficacy: over 80 percent of subjects had symptomatic relief of pelvic pain and objective improvement of endometriosis lesions (documented by pre- and post-treatment surgical staging). The main difference between the drugs was in the type and severity of side effects: danazol administration was associated with weight gain, edema, myalgia, increased circulating levels of serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and decreased levels of high-density lipoprotein (HDL) cholesterol. The most common side effects associated with nafarelin were hot flashes, decreased libido, and vaginal dryness; HDL cholesterol, AST, and ALT were not affected. Bone density was not measured.",
"   </p>",
"   <p>",
"    An advantage of GnRH agonists over",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=see_link\">",
"     danazol",
"    </a>",
"    is that the hypoestrogenic side effects associated with GnRH agonists can be minimized by add-back therapy, while androgenic side effects associated with danazol are more difficult to treat.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21664754\">",
"    <span class=\"h2\">",
"     Gonadotropin releasing hormone agonists after conservative surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether GnRH agonist therapy is useful postoperatively in women with stage III-IV endometriosis is controversial. A small retrospective study of 90 women with stage III-IV endometriosis included 16 women who received no postoperative medical therapy, 52 women who received gestrinone, and 22 women who received a GnRH agonist [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/18\">",
"     18",
"    </a>",
"    ]. The time to recurrence in the three groups was 64 months, 63 months, and 47 months, respectively. The cumulative pregnancy rates were 70 percent",
"    <span class=\"nowrap\">",
"     (7/10),",
"    </span>",
"    66.7 percent",
"    <span class=\"nowrap\">",
"     (10/15),",
"    </span>",
"    and 60 percent",
"    <span class=\"nowrap\">",
"     (6/10),",
"    </span>",
"    respectively. This study did not show improvement in pregnancy rates with endocrine therapy after conservative surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16792914\">",
"    <span class=\"h2\">",
"     Recurrence of symptomatic endometriosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the return of hormonal stimulation of the endometriotic implants or further reflux menstruation, activation of the endometriosis through ovarian function or other means may result in recurrence of endometriosis and its associated pain. It has been appreciated that GnRH agonist therapy is not useful for the treatment of infertility as the lesions are suppressed while on therapy, but &ldquo;re-activate&rdquo; soon after ovarian function returns [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/19\">",
"     19",
"    </a>",
"    ]. After surgical management, the recurrence of disease or symptoms may result from recurrence of the treated lesions or further progression of the microscopic lesions that were not treated at the time of surgery. Recurrence rates after either surgical or medical therapy are reported to be up to 45 percent after five years [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/20\">",
"     20",
"    </a>",
"    ]. For young women under the age of 21 years old diagnosed with endometriosis at laparoscopy during a five-year follow-up, 56 percent had recurrence of their symptoms. There was felt to be no association observed between the symptoms with the extent or site of the disease, the type of surgery or whether there was postsurgical medical treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/21\">",
"     21",
"    </a>",
"    ]. After GnRH agonist therapy, there is evidence that continuation of endometrial suppression with oral contraceptives reduces pain scores and the rate of subsequent hysterectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/22\">",
"     22",
"    </a>",
"    ]. In a randomized trial in which 109 women received either a GnRH agonist (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/61/26580?source=see_link\">",
"     nafarelin",
"    </a>",
"    ) or placebo followed by laparoscopic resection of endometriosis, 33 percent of the GnRH agonist treated women required additional therapy for recurrence of symptoms within 18 months [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21664761\">",
"    <span class=\"h2\">",
"     Symptomatic rectovaginal endometriosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical treatment may be effective in women with symptomatic rectovaginal endometriosis, but is associated with potentially significant morbidity and complications. A metaanalysis including 217 women with rectovaginal endometriosis evaluated the outcome of medical treatment with vaginal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=see_link\">",
"     danazol",
"    </a>",
"    , aromatase inhibitors, GnRH agonists (with add-back), and intrauterine progestin [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/24\">",
"     24",
"    </a>",
"    ]. With one exception (aromatase inhibitors used alone), 60 to 90 percent of patients treated with these therapies reported considerable reduction or complete relief from pain symptoms during the 6- to 12-month treatment period.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H207353414\">",
"    <span class=\"h1\">",
"     GnRH WITH ADD-BACK THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many women experience hypoestrogenic side effects during GnRH agonist therapy and recurrence of pain after discontinuation. Investigators have attempted to improve patient acceptance and extend duration of use by giving concomitant medications (called add-back therapy) to reduce the severity of the hypoestrogenic side effects induced by the treatment and improve quality of life (",
"    <a class=\"graphic graphic_table graphicRef58788 \" href=\"UTD.htm?43/31/44539\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14873097\">",
"    <span class=\"h2\">",
"     GnRH antagonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;GnRH antagonists are a potential therapeutic agent for endometriosis, but there are few data regarding their use in a clinical setting [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/26\">",
"     26",
"    </a>",
"    ]. One potential benefit of these agents is avoiding the initial stimulation of pituitary gonadotropins seen with GnRH agonists.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Drugs",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Progestin-only add-back",
"    </span>",
"    &nbsp;&mdash;&nbsp;The combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    depot 3.75 mg monthly injection plus a high dose progestin (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone acetate",
"    </a>",
"    5 mg orally daily) has been approved by the FDA for treatment of pelvic pain caused by endometriosis. In most women, this combination treatment is associated with both a reduction in vasomotor symptoms and preservation of bone mineral density.",
"   </p>",
"   <p>",
"    Data supporting this add-back regimen were provided by a large trial in which women with pelvic pain and endometriosis were randomly assigned to one of four year-long treatment groups: (1) GnRH agonist alone (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    acetate depot 3.75 mg intramuscularly every four weeks), (2) GnRH agonist plus a progestin (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone acetate",
"    </a>",
"    5 mg orally daily), (3) GnRH agonist plus low-dose estrogen (conjugated estrogen 0.625 mg orally daily) plus a progestin (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone",
"    </a>",
"    acetate 5 mg orally daily), (4) GnRH agonist plus high-dose estrogen (conjugated estrogen 1.25 mg orally daily) plus a progestin (norethindrone acetate 5 mg orally daily) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/9\">",
"     9",
"    </a>",
"    ]. Daily calcium supplements (1000 mg) were administered to subjects in all four groups.",
"   </p>",
"   <p>",
"    The major findings from this trial were:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Women receiving no add-back or progestin add-back with or without low-dose estrogen (0.625 mg) had a similar reduction in pelvic pain.",
"     </li>",
"     <li>",
"      Add-back with low dose estrogen (0.625 mg) was more effective than with higher dose estrogen (1.25 mg). The group taking higher dose estrogen was more likely than other groups to discontinue treatment due to pelvic pain, probably because the higher dose estrogen stimulated continued functioning and growth of the endometriosis implants. Other studies have also reported that the use of higher doses of estrogen add-back (eg, estradiol 1 mg daily) is associated with more pelvic pain than regimens that utilize lower doses of estrogen add-back [",
"      <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bone density significantly decreased in women who received a GnRH agonist (and calcium) alone, but was preserved in groups in which any hormonal add-back was included (",
"      <a class=\"graphic graphic_figure graphicRef53673 \" href=\"UTD.htm?3/30/3566\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Vasomotor symptoms were markedly reduced in all groups receiving hormonal add-back.",
"     </li>",
"     <li>",
"      In a follow-up report 12 and 24 months post-treatment, women in all treatment groups continued to have symptom scores that were below baseline for at least eight months after completion of active therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This trial proved the efficacy of add-back therapy with the combination of a GnRH agonist plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone acetate",
"    </a>",
"    . This regimen should be offered to women with chronic pelvic pain caused by endometriosis prior to considering aggressive surgical therapy (hysterectomy and bilateral salpingo-oophorectomy) since it preserves fertility potential.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Estrogen plus progestin add-back",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some women do not tolerate a high dose progestin add-back regimen because of progestin-related symptoms such as mood changes, weight gain, and bloating. The FDA has not approved a regimen of GnRH agonist with low dose estrogen plus low dose progestin add-back for treatment of pelvic pain caused by endometriosis; however, numerous clinical trials have demonstrated that this combination is effective in the treatment of pelvic pain caused by endometriosis and with a reduction in side effects observed with GnRH agonist-only treatment (eg, vasomotor symptoms, reduction in bone mineral density) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/25,29-34\">",
"     25,29-34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As an example, in one trial, women with endometriosis and pelvic pain were randomly assigned to receive either a GnRH agonist alone or a GnRH agonist plus low dose estradiol (transdermal estradiol 25 mcg per day) plus low dose progestin (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    2.5 mg orally daily) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/29\">",
"     29",
"    </a>",
"    ]. The two groups had equivalent reductions in both pelvic pain symptom scores and endometriosis lesion activity as determined by surgical staging (",
"    <a class=\"graphic graphic_figure graphicRef66544 \" href=\"UTD.htm?18/35/18993\">",
"     figure 2",
"    </a>",
"    ). Compared to women who received estrogen-progestin add-back, women who received the GnRH agonist alone reported more vasomotor symptoms and greater bone loss was noted by dual energy x-ray absorptiometry of the spine.",
"   </p>",
"   <p>",
"    This study suggests that control of symptoms and disease activity can be achieved and induction of hypoestrogenic side effects reduced by administering a GnRH agonist plus low dose estrogen-progestin add-back. Of some concern, bone mineral density loss occurred despite administration of very low doses of these hormones (",
"    <a class=\"graphic graphic_figure graphicRef70640 \" href=\"UTD.htm?21/22/21871\">",
"     figure 3",
"    </a>",
"    ). By comparison, the add-back trial described above showed add-back with a high dose progestin (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone acetate",
"    </a>",
"    5 mg daily) with or without estrogen was not associated with a significant decline in bone density (",
"    <a class=\"graphic graphic_figure graphicRef53673 \" href=\"UTD.htm?3/30/3566\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/9\">",
"     9",
"    </a>",
"    ]. While patient compliance with GnRH therapy for women with endometriosis is not high, compliance is improved with the use of add-back therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We advise clinicians to use the FDA-approved regimen of a GnRH agonist plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone acetate",
"    </a>",
"    (5 mg) as first-line therapy. For women who have significant side effects from the high dose progestin, a trial of estrogen-low dose progestin add-back (eg, conjugated estrogen 0.625 mg plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    5 mg orally) is reasonable. Fewer than 10 percent of women on this regimen will have vaginal bleeding. Both the GnRH-agonist and add-back are initiated with onset of menses; there is no advantage to beginning the agonist without add-back therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Nonsteroidal add-back",
"    </span>",
"    &nbsp;&mdash;&nbsp;An alternative to steroidal add-back therapy is the use of nonsteroidal medicines to treat hypoestrogenic side effects. Many nonsteroidal regimens have been proposed to treat menopausal symptoms and accelerated bone loss. Although estrogen and high dose progestins are the most effective treatments for vasomotor symptoms caused by hypoestrogenism, herbal remedies [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/36\">",
"     36",
"    </a>",
"    ], selective serotonin reuptake inhibitors (SSRIs), and",
"    <span class=\"nowrap\">",
"     serotonin/norepinephrine",
"    </span>",
"    reuptake inhibitors (SNRIs) have been reported to have some efficacy. For women with accelerated bone loss, weight bearing exercise, calcium, and vitamin D supplementation have modest efficacy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/53/25434?source=see_link\">",
"     \"Menopausal hot flashes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39754?source=see_link\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bisphosphonates are effective for restoring bone density and preventing fractures in women with osteopenia. Since most bisphosphonates are slowly released from the bone into the circulation for many years after treatment is discontinued, some experts are concerned that use of these drugs in women who are planning future pregnancies may expose the fetus and adversely affect fetal bone development [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/37\">",
"     37",
"    </a>",
"    ]. About two dozen cases of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/10/24743?source=see_link\">",
"     alendronate",
"    </a>",
"    exposure prior to or during pregnancy have been described without reports of congenital anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3360141\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are minimal data on estrogen-only add-back. This approach has generally been avoided due to concerns about stimulating endometriosis, leading to increased pain, and stimulating eutopic endometrium, leading to endometrial hyperplasia. A double-blind trial randomly assigned 13 women with endometriosis-related pain treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    acetate to add-back with oral estradiol 1 mg daily or an identical placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/27\">",
"     27",
"    </a>",
"    ]. The trial was terminated early because of a trend toward increasing endometriosis-related pain in the estradiol group. A retrospective cohort study of 117 women who underwent conservative laparoscopic surgery followed by leuprorelin acetate and short-term add-back with tibolone or estradiol (1 mg) found no difference in pain scores between the two regimens [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/39\">",
"     39",
"    </a>",
"    ]. Low or micro-dose estrogen add-back (eg, transdermal estradiol 0.014 to 0.025",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    is unlikely to cause recurrence of endometriosis pain or endometrial hyperplasia, and can be effective in relieving vasomotor symptoms and urogenital dryness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Concurrent versus delayed initiation of hormonal add-back",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common regimen for add-back is to begin GnRH agonist therapy with steroid add-back at the same time. The advantage of this approach is that it will markedly reduce the likelihood that the woman will experience vasomotor symptoms and maximally preserves bone density. However, multiple drugs are initiated at once, a situation that might not be acceptable to all patients.",
"   </p>",
"   <p>",
"    Alternatively, one can administer a GnRH agonist alone for one to six months, then, if the intent is to continue GnRH agonist therapy, steroid add-back is begun. The advantages of this approach are that it allows the clinician time to determine if treatment with GnRH will be successful and to gauge the severity of the individual woman's hypoestrogenic side effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A short course of therapy (eg, three months) can provide effective relief, but pain is likely to return after discontinuation of the medication [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/40\">",
"     40",
"    </a>",
"    ]. Use of GnRH agonist (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    acetate depot 3.75 mg monthly) plus high-dose progestin add-back (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone acetate",
"    </a>",
"    5 mg daily) has not been approved for use beyond 12 months by the FDA, as the safety and efficacy of extended therapy have not been evaluated extensively. However, a small number of clinical trials and small cohort studies have demonstrated that a GnRH agonist plus steroid add-back can be effective from 30 months to up to 10 years of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. We individualize duration of treatment according to the symptoms and reproductive plans of each patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1603869717\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone loss can occur despite add-back therapy; the magnitude of decline depends upon the add-back regimen used and the individual woman's bone-mineral response to therapy. To assess the effects of treatment on each woman, we suggest that bone density be measured yearly in women who are receiving long-term GnRH agonist therapy, regardless of the add-back regimen used. Because adolescence is a particularly important time for normal skeletonization, close monitoring of adolescents is indicated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11402?source=see_link\">",
"     \"Diagnosis and treatment of endometriosis in adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Long-term use of GnRH agonists with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone acetate",
"    </a>",
"    5 mg alone for add-back therapy can lead to a significant reduction in HDL cholesterol and significant increases in LDL cholesterol and triglycerides [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/17\">",
"     17",
"    </a>",
"    ]. Lipid levels should be monitored in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/43\">",
"     43",
"    </a>",
"    ]; however, the appropriate interval for such testing has not been determined. When estrogen or medroxyprogesterone is used for add-back, lipid levels remain stable so monitoring is unnecessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     LOW DOSE GNRH",
"    </span>",
"    &nbsp;&mdash;&nbsp;An alternative to add-back therapy for treatment of the hypoestrogenic state is to decrease the dose of GnRH agonist or increase the interval between doses. This reduces the magnitude of suppression of LH and FSH and allows some ovarian estrogen secretion. We employ this regimen when we need to use GnRH agonists for more than six months without add-back therapy.",
"   </p>",
"   <p>",
"    Body mass index (BMI) is probably an important variable in predicting whether dose reduction or extended interval dosing will be effective. Women with a BMI less than 25",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    who also exercise intensively are the most likely to reliably respond to these lower dose regimens. Women with BMI greater than 30",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    are less likely to achieve amenorrhea and reduction in pelvic pain.",
"   </p>",
"   <p>",
"    Two options for lowering the GnRH dose are:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Titration method",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initiate therapy with a standard dose of daily GnRH agonist (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/61/26580?source=see_link\">",
"     nafarelin",
"    </a>",
"    200 mcg [1 spray into a nostril] in the morning and again at night). After one to three months, suppression of ovarian estrogen secretion and amenorrhea will have been achieved in most patients and pelvic pain should be improved. At this point, the dose of nafarelin can be decreased to two nasal sprays on even days and one nasal spray on odd days of the month. This is an approximately 25 percent reduction in the dose of GnRH agonist.",
"   </p>",
"   <p>",
"    At this lower dose, many women will note fewer vasomotor symptoms, but with continued amenorrhea and relief of pelvic pain. A small number of women can reduce the dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/61/26580?source=see_link\">",
"     nafarelin",
"    </a>",
"    further to as little as one nasal spray daily and remain amenorrheic. If menses or pain recurs, the dose can be increased to achieve more complete suppression of pituitary LH and FSH secretion, and, in turn, ovarian estrogen secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/44-46\">",
"     44-46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Longer interval method",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another approach is to increase the time interval between depot injections of the GnRH agonist from four to six weeks. As an example, in one study, women with endometriosis and pelvic pain were randomly assigned to receive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/11/9398?source=see_link\">",
"     triptorelin",
"    </a>",
"    depot 3.75 mg intramuscularly every four weeks (standard regimen) or every six weeks (extended interval dosing) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/47\">",
"     47",
"    </a>",
"    ]. Women in both groups had similar improvement in pelvic pain, with a reduction in cost due to less frequent administration. Others have also reported equivalent relief of dysmenorrhea in women treated with standard monthly injection of triptorelin and those who received an extended-interval dosing regimen of every six weeks over a six-month interval [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Addition of an aromatase inhibitor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ovarian estrogen production is just one of the three sources of estrogen that may stimulate endometrial implants. The other two sources are peripheral conversion of precursors in adipose tissue and local production of estrogens in the implants themselves. In women with suboptimal pain relief after use of GnRH agonists, the addition of an aromatase inhibitor can be helpful. In a six-month trial comparing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/49/22294?source=see_link\">",
"     anastrozole",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/22/9574?source=see_link\">",
"     goserelin",
"    </a>",
"    versus goserelin alone, statistically significant increases in the pain-free interval and decreased symptom recurrence rates were observed in the",
"    <span class=\"nowrap\">",
"     anastrozole/goserelin-treated",
"    </span>",
"    subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     ALTERNATIVES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a growing body of experience with the levonorgestrel-releasing intrauterine device (LNG-IUD) for management of endometriosis. The following preliminary studies suggest the LNG-IUD may be an alternative to GnRH agonists and their long-term side effects. More experience is warranted.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized trial of 40 parous women with moderate or severe dysmenorrhea undergoing operative laparoscopy for treatment of symptomatic endometriosis compared the effect of immediate postoperative insertion of a LNG-IUD versus surgery alone [",
"      <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/50\">",
"       50",
"      </a>",
"      ]. One year postoperatively, moderate or severe dysmenorrhea occurred significantly less often in the LNG-IUD group",
"      <span class=\"nowrap\">",
"       (2/20",
"      </span>",
"      subjects [10 percent] versus",
"      <span class=\"nowrap\">",
"       9/20",
"      </span>",
"      [45 percent]; OR 0.14, 95% CI 0.02-0.75), resulting in greater patient satisfaction (OR 3.00, 95% CI 0.79-11.44) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/50,51\">",
"       50,51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another study comparing lipids and other cardiovascular variables (interleukin-6, C-reactive protein, vascular cell adhesion molecules) between LNG-IUD subjects and those receiving a GnRH agonist, there were more favorable changes seen in the LNG-IUD group [",
"      <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study of 22 women experiencing pain related to endometriosis compared the effects of six months treatment with a LNG-IUD (n = 11) versus a GnRH agonist (n = 11) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/35/8761/abstract/53\">",
"       53",
"      </a>",
"      ]. Pre- and post-treatment specimens of eutopic and ectopic endometrium were evaluated for both proliferative and apoptosis markers, and hormone receptors. The cell proliferation index was significantly reduced in the epithelium and stroma of both eutopic and ectopic endometrium in both treatment groups. Only the IUD users showed an increased H-score for Fas in both tissues (p&lt;0.05). In eutopic endometrium, both treatments lowered expression of ER-alpha and PR-A, whereas in ectopic endometrium, only LNG-IUD treatment lowered expression. This demonstrates that, unexpectedly, the &lsquo;local&rsquo; application of a levonorgestrel-releasing IUD produced therapeutic effects on the ectopic endometrium and an even greater apoptotic effect than a GnRH agonist.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An overview of the various medical and surgical treatments for endometriosis can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link\">",
"     \"Overview of the treatment of endometriosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A hypoestrogenic state leads to atrophy of ectopic endometrium and consistently reduces or eliminates endometriosis-related pain. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Basis for hormonal treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women with chronic endometriosis-related pelvic pain, we suggest a GnRH agonist rather than",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=see_link\">",
"       danazol",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). GnRH agonists have a more favorable side-effect profile and, unlike oophorectomy, do not impair fertility. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Efficacy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Add-back therapy results in fewer vasomotor symptoms and less bone loss than when a GnRH agonist is used as monotherapy. Several add-back options are available (",
"      <a class=\"graphic graphic_table graphicRef58788 \" href=\"UTD.htm?43/31/44539\">",
"       table 3",
"      </a>",
"      ). We individualize duration of treatment according to the symptoms and reproductive plans of each patient. (See",
"      <a class=\"local\" href=\"#H207353414\">",
"       'GnRH with add-back therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We suggest a GnRH agonist plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"       norethindrone acetate",
"      </a>",
"      (5 mg) as first-line therapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). This regimen appears to preserve bone mineral density better than low-dose estrogen-progestin add-back. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Progestin-only add-back'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women who have significant side effects from the high dose progestin, we suggest a GnRH agonist plus low dose estrogen and progestin add-back (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Estrogen plus progestin add-back'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If steroidal add-back therapy is not possible, we suggest decreasing the dose of GnRH agonist or increasing the interval between doses (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Low dose GnRH'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/1\">",
"      Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update 2009; 15:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/2\">",
"      Ling FW. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Pelvic Pain Study Group. Obstet Gynecol 1999; 93:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/3\">",
"      Bulun SE. Endometriosis. N Engl J Med 2009; 360:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/4\">",
"      Ranney B. Endometriosis. 3. Complete operations. Reasons, sequelae, treatment. Am J Obstet Gynecol 1971; 109:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/5\">",
"      Gray LA. Endometriosis of the bowel: role of bowel resection, superficial excision and oophorectomy in treatment. Ann Surg 1973; 177:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/6\">",
"      Hammond CB, Rock JA, Parker RT. Conservative treatment of endometriosis: the effects of limited surgery and hormonal pseudopregnancy. Fertil Steril 1976; 27:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/7\">",
"      Conn PM, Crowley WF Jr. Gonadotropin-releasing hormone and its analogues. N Engl J Med 1991; 324:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/8\">",
"      Levine D, Kaufman L, Cuenca VG, Badawy SZ. Cell growth effects of leuprolide on cultured endometrioma cells. J Reprod Med 2007; 52:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/9\">",
"      Hornstein MD, Surrey ES, Weisberg GW, Casino LA. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group. Obstet Gynecol 1998; 91:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/10\">",
"      Dlugi AM, Miller JD, Knittle J. Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group. Fertil Steril 1990; 54:419.",
"     </a>",
"    </li>",
"    <li>",
"     FDA Drug Safety Communication: Update to Ongoing Safety Review of GnRH Agonists and Notification to Manufacturers of GnRH Agonists to Add New Safety Information to Labeling Regarding Increased Risk of Diabetes and Certain Cardiovascular Diseases",
" file://www.fda.gov/Drugs/DrugSafety/ucm229986.htm (Accessed on October 21, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/12\">",
"      Henzl MR, Corson SL, Moghissi K, et al. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. N Engl J Med 1988; 318:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/13\">",
"      Barbieri RL. New therapy for endometriosis. N Engl J Med 1988; 318:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/14\">",
"      Barbieri RL. Comparison of the pharmacology of nafarelin and danazol. Am J Obstet Gynecol 1990; 162:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/15\">",
"      Prentice A, Deary AJ, Goldbeck-Wood S, et al. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev 2000; :CD000346.",
"     </a>",
"    </li>",
"    <li>",
"     Shaw, RW. Goserelin depot preparation of LHRH analogue used in the treatment of endometriosis. In: Current concepts in endometriosis, Chadha, DR Buttram, VC (Eds), Alan R. Liss, New York 1990. p.323.",
"    </li>",
"    <li>",
"     Cirkel, U, Schweppe, KW, Ochs, H, et al. Effects of LHRH agonist therapy in the treatment of endometriosis. In: Gonadotropin down-regulation in gynecological practice. Vol 225, Chadha, DR, Willemsen, WNP (Eds). Aln R Liss, New York 1986. p. 189.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/18\">",
"      Li Y, Zhu HL, Liang XD, et al. [Outcome analysis of stage III - IV endometriosis after conservative surgery]. Zhonghua Fu Chan Ke Za Zhi 2007; 42:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/19\">",
"      Evers JL. The second-look laparoscopy for evaluation of the result of medical treatment of endometriosis should not be performed during ovarian suppression. Fertil Steril 1987; 47:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/20\">",
"      Evers JL, Dunselman GA, Land JA, Bouckaert PX. Is there a solution for recurrent endometriosis? Br J Clin Pract Suppl 1991; 72:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/21\">",
"      Tandoi I, Somigliana E, Riparini J, et al. High rate of endometriosis recurrence in young women. J Pediatr Adolesc Gynecol 2011; 24:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/22\">",
"      Szendei G, Hern&aacute;di Z, D&eacute;v&eacute;nyi N, Csap&oacute; Z. Is there any correlation between stages of endometriosis and severity of chronic pelvic pain? Possibilities of treatment. Gynecol Endocrinol 2005; 21:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/23\">",
"      Hornstein MD, Hemmings R, Yuzpe AA, Heinrichs WL. Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis. Fertil Steril 1997; 68:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/24\">",
"      Vercellini P, Crosignani PG, Somigliana E, et al. Medical treatment for rectovaginal endometriosis: what is the evidence? Hum Reprod 2009; 24:2504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/25\">",
"      Zupi E, Marconi D, Sbracia M, et al. Add-back therapy in the treatment of endometriosis-associated pain. Fertil Steril 2004; 82:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/26\">",
"      K&uuml;pker W, Felberbaum RE, Krapp M, et al. Use of GnRH antagonists in the treatment of endometriosis. Reprod Biomed Online 2002; 5:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/27\">",
"      Hurst BS, Gardner SC, Tucker KE, et al. Delayed oral estradiol combined with leuprolide increases endometriosis-related pain. JSLS 2000; 4:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/28\">",
"      Surrey ES, Hornstein MD. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up. Obstet Gynecol 2002; 99:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/29\">",
"      Howell R, Edmonds DK, Dowsett M, et al. Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial. Fertil Steril 1995; 64:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/30\">",
"      Moghissi KS, Schlaff WD, Olive DL, et al. Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis. Fertil Steril 1998; 69:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/31\">",
"      Irahara M, Uemura H, Yasui T, et al. Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis. Gynecol Obstet Invest 2001; 52:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/32\">",
"      Pierce SJ, Gazvani MR, Farquharson RG. Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up. Fertil Steril 2000; 74:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/33\">",
"      Kiilholma P, Tuimala R, Kivinen S, et al. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis. Fertil Steril 1995; 64:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/34\">",
"      Franke HR, van de Weijer PH, Pennings TM, van der Mooren MJ. Gonadotropin-releasing hormone agonist plus \"add-back\" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial. Fertil Steril 2000; 74:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/35\">",
"      Fuldeore MJ, Marx SE, Chwalisz K, et al. Add-back therapy use and its impact on LA persistence in patients with endometriosis. Curr Med Res Opin 2010; 26:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/36\">",
"      Tanaka T. Effects of herbal medicines on menopausal symptoms induced by gonadotropin-releasing hormone agonist therapy. Clin Exp Obstet Gynecol 2001; 28:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/37\">",
"      Surrey ES. Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Add-Back Consensus Working Group. Fertil Steril 1999; 71:420.",
"     </a>",
"    </li>",
"    <li>",
"     www.Reprotox.com (Accessed April 10, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/39\">",
"      Kim NY, Ryoo U, Lee DY, et al. The efficacy and tolerability of short-term low-dose estrogen-only add-back therapy during post-operative GnRH agonist treatment for endometriosis. Eur J Obstet Gynecol Reprod Biol 2011; 154:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/40\">",
"      Hornstein MD, Yuzpe AA, Burry KA, et al. Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain. Fertil Steril 1995; 63:955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/41\">",
"      Mitwally MF, Gotlieb L, Casper RF. Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome. Menopause 2002; 9:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/42\">",
"      Bedaiwy MA, Casper RF. Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain. Fertil Steril 2006; 86:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/43\">",
"      Practice bulletin no. 114: management of endometriosis. Obstet Gynecol 2010; 116:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/44\">",
"      Hull ME, Barbieri RL. Nafarelin in the treatment of endometriosis. Dose management. Gynecol Obstet Invest 1994; 37:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/45\">",
"      Tahara M, Matsuoka T, Yokoi T, et al. Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (\"draw-back\" therapy). Fertil Steril 2000; 73:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/46\">",
"      Uemura T, Shirasu K, Katagiri N, et al. Low-dose GnRH agonist therapy for the management of endometriosis. J Obstet Gynaecol Res 1999; 25:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/47\">",
"      Tse CY, Chow AM, Chan SC. Effects of an extended-interval dosing regimen of triptorelin depot on the hormonal profile of patients with endometriosis: prospective observational study. Hong Kong Med J 2000; 6:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/48\">",
"      Kang JL, Wang XX, Nie ML, Huang XH. Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis. Gynecol Obstet Invest 2010; 69:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/49\">",
"      Soysal S, Soysal ME, Ozer S, et al. The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod 2004; 19:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/50\">",
"      Vercellini P, Frontino G, De Giorgi O, et al. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril 2003; 80:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/51\">",
"      Abou-Setta AM, Al-Inany HG, Farquhar CM. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev 2006; :CD005072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/52\">",
"      Ferreira RA, Vieira CS, Rosa-E-Silva JC, et al. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue. Contraception 2010; 81:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/35/8761/abstract/53\">",
"      Gomes MK, Rosa-e-Silva JC, Garcia SB, et al. Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium. Hum Reprod 2009; 24:2736.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7416 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-189.41.181.191-2D925142A9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8761=[""].join("\n");
var outline_f8_35_8761=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BASIS FOR HORMONAL TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PHARMACOLOGY OF GnRH AGONISTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H276284642\">",
"      Side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EFFICACY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21664754\">",
"      Gonadotropin releasing hormone agonists after conservative surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16792914\">",
"      Recurrence of symptomatic endometriosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21664761\">",
"      Symptomatic rectovaginal endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H207353414\">",
"      GnRH WITH ADD-BACK THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14873097\">",
"      GnRH antagonists",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Progestin-only add-back",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Estrogen plus progestin add-back",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Nonsteroidal add-back",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3360141\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Concurrent versus delayed initiation of hormonal add-back",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1603869717\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      LOW DOSE GNRH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Titration method",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Longer interval method",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Addition of an aromatase inhibitor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      ALTERNATIVES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/7416\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/7416|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/30/3566\" title=\"figure 1\">",
"      Change BMD with add-back rx",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/35/18993\" title=\"figure 2\">",
"      GnRH vs GnRH with addback",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/22/21871\" title=\"figure 3\">",
"      Change BMD low dose addback",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/7416|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/10/5291\" title=\"table 1\">",
"      GnRH agonist dosing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/26/37292\" title=\"table 2\">",
"      Amino acid composition GnRHa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/31/44539\" title=\"table 3\">",
"      GnRH add back regimens",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11402?source=related_link\">",
"      Diagnosis and treatment of endometriosis in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/53/25434?source=related_link\">",
"      Menopausal hot flashes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39754?source=related_link\">",
"      Overview of the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=related_link\">",
"      Overview of the treatment of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28969?source=related_link\">",
"      Treatment of chronic pelvic pain in women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_35_8762="ECG Brugada syndrome type I pattern";
var content_f8_35_8762=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F64510&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F64510&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1056px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    12-lead electrocardiogram (ECG) from a patient with the Brugada syndrome shows downsloping ST elevation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 429px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    ST segment elevation and T wave inversion in the right precordial leads V1 and V2 (arrows); the QRS is normal. The widened S wave in left lateral leads that is characteristic of right bundle branch block is absent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr Rory Childers, University of Chicago.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 466px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 466px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal sinus rhythm at a rate of 71 beats/min, a P wave axis of 45&deg;, and a PR interval of 0.15 sec.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8762=[""].join("\n");
var outline_f8_35_8762=null;
var title_f8_35_8763="Medication overuse headache criteria";
var content_f8_35_8763=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F71798&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F71798&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Revised International Headache Society criteria for medication overuse headache",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        A. Headache present on &ge;15 days a month",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B. Regular overuse for more than three months of one or more acute/symptomatic treatment drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Ergotamine, triptans, opioids,",
"        <strong>",
"         or",
"        </strong>",
"        combination analgesic medications on &ge;10 days a month on a regular basis for more than three months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Simple analgesics",
"        <strong>",
"         or",
"        </strong>",
"        any combination of ergotamine, triptans, analgesic opioids on &ge;15 days a month on a regular basis for more than three months without overuse of any single class alone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C. Headache has developed or markedly worsened during medication overuse",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006; 26:742. Copyright &copy; 2006 Sage Publications. Reprinted by permission of Sage.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8763=[""].join("\n");
var outline_f8_35_8763=null;
var title_f8_35_8764="Rai staging system CLL";
var content_f8_35_8764=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F56284%7EHEME%2F80421&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F56284%7EHEME%2F80421&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Modified Rai clinical staging system for chronic lymphocytic leukemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Risk",
"       </td>",
"       <td class=\"subtitle1\">",
"        Stage",
"       </td>",
"       <td class=\"subtitle1\">",
"        Description",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        Lymphocytosis in blood or bone marrow",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Intermediate",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        Lymphocytosis + enlarged lymph nodes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        II",
"       </td>",
"       <td>",
"        Lymphocytosis + enlarged liver or spleen with or",
"without lymphadenopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        High",
"       </td>",
"       <td>",
"        III",
"       </td>",
"       <td>",
"        Lymphocytosis + anemia (Hgb &lt;11 g/dL)",
"with&nbsp;or without enlarged liver, spleen, or lymph lnodes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        Lymphocytosis + thrombocytopenia (platelet count",
"&lt;100,000/&micro;L) with or without anemia or enlarged liver,",
"spleen, or lymph nodes",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Binet Staging System For Chronic Lymphocytic Leukemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Stage",
"      </td>",
"      <td class=\"subtitle1\">",
"       Description",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       A",
"      </td>",
"      <td>",
"       Two or less lymphoid bearing areas enlarged*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       B",
"      </td>",
"      <td>",
"       Three or more lymphoid bearing areas enlarged*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       C",
"      </td>",
"      <td>",
"       Presence of anemia (Hgb &lt;10.0 g/dL) or thrombocytopenia (platelet count &lt;100,000/microL)",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Five lymphoid bearing areas are possible: cervical, axillary, inguino-femoral, spleen, and liver.",
"    </div>",
"    <div class=\"reference\">",
"     Revised from Binet, JL, Auquier, A, Dighiero, G, et al. Cancer 1981; 48:198.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8764=[""].join("\n");
var outline_f8_35_8764=null;
var title_f8_35_8765="Antiarrhythmic drugs in pregnancy";
var content_f8_35_8765=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F50716&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F50716&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Antiarrhythmic drugs in pregnancy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Pregnancy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Breastfeeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amiodarone",
"       </td>",
"       <td>",
"        Has been associated with serious adverse effects. Congenital goiter/hypothyroidism and hyperthyroidism can occur after in utero exposure. Other potential risks include prolonged QT interval in neonates.",
"       </td>",
"       <td>",
"        Not recommended because of potential risk of hypothyroidism in neonate.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Beta blockers",
"       </td>",
"       <td>",
"        <p>",
"         No evidence of increased risk of teratogenesis, but some (particularly atenolol) may impair fetal growth when used for a prolonged duration in the second and third trimesters. Use only in the third trimester is associated with reduced placental weight.",
"        </p>",
"        <p>",
"         Newborns of women taking these drugs near delivery are at risk of bradycardia, hypoglycemia, and other symptoms of beta-blockade.",
"        </p>",
"        <p>",
"         Among this class of drugs, atenolol appears to have the most unfavorable effect on birthweight.",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         AAP considers these agents compatible with breastfeeding, but newborns should be observed for signs of beta-blockade.",
"        </p>",
"        <p>",
"         Atenolol is a weak base that will accumulate in milk. Accumulation is enhanced by its water-soluble, low protein binding, little or no hepatic metabolism, and renal excretion properties. Because it has been associated with beta-blocking effects and cyanosis in nursing infants, it is best avoided during breast feeding.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sotalol",
"       </td>",
"       <td>",
"        Sotalol, which has both beta blocker and type III antiarrhthmic properties, is not teratogenic, and its use has not been associated with fetal growth restriction. Its use near birth has been associated with newborn bradycardia.",
"       </td>",
"       <td>",
"        Sotalol is concentrated in breast milk, with milk levels several-fold higher than those in maternal plasma, so close monitoring for bradycardia, hypotension, respiratory distress, and hypoglycemia is advised.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adenosine",
"       </td>",
"       <td>",
"        No evidence of increased risk of teratogenesis or increased risk of adverse fetal/neonatal effects.",
"       </td>",
"       <td>",
"        No information. Because of very short half-life, it is unlikely to have any adverse effects on the neonate.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Digoxin",
"       </td>",
"       <td>",
"        No evidence of increased risk of teratogenesis or increased risk of adverse fetal/neonatal effects.",
"       </td>",
"       <td>",
"        AAP considers digoxin compatible with breastfeeding.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Verapamil",
"       </td>",
"       <td>",
"        No evidence of increased risk of teratogenesis or increased risk of adverse fetal/neonatal effects.",
"       </td>",
"       <td>",
"        AAP considers verapamil compatible with breastfeeding.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Procainamide",
"       </td>",
"       <td>",
"        No evidence of increased risk of teratogenesis or increased risk of adverse fetal/neonatal effects.",
"       </td>",
"       <td>",
"        AAP classifies procainamide as compatible with breastfeeding. However, the long-term effects of exposure in the nursing infant are unknown, particularly with respect to potential drug toxicity (eg, development of antinuclear antibodies and lupus-like syndrome).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Quinidine",
"       </td>",
"       <td>",
"        No evidence of increased risk of teratogenesis. In therapeutic doses, the oxytocic properties of quinidine have been rarely observed, but high doses can produce this effect and may result in preterm labor or abortion.",
"       </td>",
"       <td>",
"        AAP considers quinidine compatible with breastfeeding.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Flecainide",
"       </td>",
"       <td>",
"        Developmental toxicity has been noted in animals, but limited information on human risk from early pregnancy exposure. This risk appears to be low when used for refractory fetal arrhythmia. It may be the treatment of choice for tachycardia in hydropic fetuses.",
"       </td>",
"       <td>",
"        AAP considers flecainide compatible with breastfeeding.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, 8th edition. Philadelphia: Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8765=[""].join("\n");
var outline_f8_35_8765=null;
var title_f8_35_8766="TNM staging GIST";
var content_f8_35_8766=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F51606&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F51606&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    TNM staging for gastrointestinal stromal tumors (GIST)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"5\">",
"        For GISTs at all sites",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Primary tumor (T)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        TX",
"       </td>",
"       <td colspan=\"4\">",
"        Primary tumor cannot be assessed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        T0",
"       </td>",
"       <td colspan=\"4\">",
"        No evidence for primary tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        T1",
"       </td>",
"       <td colspan=\"4\">",
"        Tumor 2 cm or less",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        T2",
"       </td>",
"       <td colspan=\"4\">",
"        Tumor more than 2 cm but not more than 5 cm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        T3",
"       </td>",
"       <td colspan=\"4\">",
"        Tumor more than 5 cm but not more than 10 cm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        T4",
"       </td>",
"       <td colspan=\"4\">",
"        Tumor more than 10 cm in greatest dimension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Regional lymph nodes (N)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        N0",
"       </td>",
"       <td colspan=\"4\">",
"        No regional lymph node metastasis*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        N1",
"       </td>",
"       <td colspan=\"4\">",
"        Regional lymph node metastasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Distant metastasis (M)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        M0",
"       </td>",
"       <td colspan=\"4\">",
"        No distant metastasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        M1",
"       </td>",
"       <td colspan=\"4\">",
"        Distant metastasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Histologic grade (G)",
"        <span class=\"small\">",
"         &bull;",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        GX",
"       </td>",
"       <td colspan=\"4\">",
"        Grade cannot be assessed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        G1",
"       </td>",
"       <td colspan=\"4\">",
"        Low grade; mitotic rate &le;5/50 HPF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        G2",
"       </td>",
"       <td colspan=\"4\">",
"        High grade; mitotic rate &gt;5/50 HPF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Anatomic stage/prognostic groups",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle4\">",
"        Stage",
"       </td>",
"       <td class=\"subtitle4\">",
"        T",
"       </td>",
"       <td class=\"subtitle4\">",
"        N",
"       </td>",
"       <td class=\"subtitle4\">",
"        M",
"       </td>",
"       <td class=\"subtitle4\">",
"        Mitotic rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"5\">",
"        Gastric GIST&Delta;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        IA",
"       </td>",
"       <td>",
"        T1 or T2",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        IB",
"       </td>",
"       <td>",
"        T3",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" rowspan=\"3\">",
"        II",
"       </td>",
"       <td>",
"        T1",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T2",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T4",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        IIIA",
"       </td>",
"       <td>",
"        T3",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        IIIB",
"       </td>",
"       <td>",
"        T4",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" rowspan=\"2\">",
"        IV",
"       </td>",
"       <td>",
"        Any T",
"       </td>",
"       <td>",
"        N1",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Any rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any T",
"       </td>",
"       <td>",
"        Any N",
"       </td>",
"       <td>",
"        M1",
"       </td>",
"       <td>",
"        Any rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"5\">",
"        Small intestinal GIST&loz;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        I",
"       </td>",
"       <td>",
"        T1 or T2",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        II",
"       </td>",
"       <td>",
"        T3",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" rowspan=\"2\">",
"        IIIA",
"       </td>",
"       <td>",
"        T1",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T4",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" rowspan=\"3\">",
"        IIIB",
"       </td>",
"       <td>",
"        T2",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T3",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T4",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" rowspan=\"2\">",
"        IV",
"       </td>",
"       <td>",
"        Any T",
"       </td>",
"       <td>",
"        N1",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Any rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any T",
"       </td>",
"       <td>",
"        Any N",
"       </td>",
"       <td>",
"        M1",
"       </td>",
"       <td>",
"        Any rate",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Note: cTNM is the clinical classification, pTNM is the pathologic classification.",
"    <div class=\"footnotes\">",
"     * If regional node status is unknown, use N0 not NX.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Histologic grading, an ingredient in sarcoma staging, is not well suited to GISTs, because a majority of these tumors have low or relatively low mitotic rates below the thresholds used for grading of soft tissue tumors, and because GISTs often manifest aggressive features with mitotic rates below the thresholds used for soft tissue tumor grading (the lowest tier of mitotic rates for soft tissue sarcomas being 10 mitoses per 10 HPFs). In GIST staging, the grade is replaced by mitotic activity.",
"      <br>",
"       &Delta; Also to be used for omentum.",
"       <br>",
"        <span class=\"lozenge\">",
"         &loz;",
"        </span>",
"        Also to be used for esophagus, colorectal, mesentary, and peritoneum.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8766=[""].join("\n");
var outline_f8_35_8766=null;
var title_f8_35_8767="High grade cystic duct leak II";
var content_f8_35_8767=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F70108&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F70108&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    High grade cystic stump leak after cholecystectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 249px; height: 332px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    ERCP shows extravasation of contrast (arrow) with minimal filling of the intraheptic bile ducts.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael J Bourke, MBBS, FRACP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_35_8767=[""].join("\n");
var outline_f8_35_8767=null;
